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  The advent of high-speed computers, availability of sophisticated algorithms, 
and state of-the-art computer graphics have made plausible the use of 
computationally intensive methods such as quantum mechanics, molecular 
mechanics, and molecular dynamics simulations to determine those physical and 
structural properties most commonly involved in molecular processes. The power of 
molecular modeling rests solidly on a variety of well established scientific disciplines 
including computer science, theoretical chemistry, biochemistry, and biophysics. 
Molecular modeling has become an indispensable complementary tool for most 
experimental scientific research [1]. 
  Molecular modeling is focused on applying the fundamental laws of physics 
and chemistry to the study of molecules. The ultimate aim is to create models and 
simulations, which can help by predicting, rationalizing, and estimating the properties 
of molecules and their interactions. Today, computational techniques performed by 
powerful computers have revolutionized molecular modelling to the extent that most 
calculations could not be performed without the use of a computer [2]. 
  It allows chemists to study chemical phenomena by running calculations on 
computers rather than by examining reactions and compounds experimentally. Some 
methods can be used to model not only stable molecules, but also short-lived, 
unstable intermediates and even transition states. In this way, they can provide 
information about molecules and reactions, which is impossible to obtain through 
observations. Molecular modelling and computational chemistry is therefore both an 
independent research area and a vital adjunct to experimental studies [2]. 
  Quantum chemistry methods play an important role in obtaining molecular 
geometries and predicting various properties [3]. To obtain highly accurate 





elements, expensive ab initio/HF electron correlation methods are required [4-6]. 
Density functional theory methods offer an alternative use of inexpensive 
computational methods, which could handle relatively large molecules. [7-16] 
  Quantitative structure – activity relationships (QSARs), as one of the most 
important areas in chemometrics [17]. QSARs are a suite of tools used to link 
chemical activities with molecular structure and composition [18], and is actively 
used in drug design [19, 20]. The concept of using QSARs to link structure and activity 
was introduced over 100 years ago and subsequently widely used in medical and 
biological research [21,22]. To develop a QSAR model, several statistic methods can 
be used [23]. 
  Druglikeness is a qualitative concept used in drug design, which is estimated 
from the molecular structure before the substance is even synthesized and tested. 
The calculation of drug-like property can give us better assumption of biological 
activity of certain molecule. The theoretical calculation and maintain of certain 
properties of a molecule can fulfill the parameters which are essential to show 
certain biological activity. Lipinski's rule of five is a rule of thumb to evaluate 
druglikeness or determine a chemical compound with a certain pharmacological or 
biological activity that would make it a likely orally active drug in humans [24]. 
   Drug-likeness appears as a promising paradigm to encode the balance among 
the molecular properties of a compound that influences its pharmacodynamics and 
pharmacokinetics and ultimately optimizes their absorption, distribution, metabolism 
and excretion (ADME) in human body like a drug [25, 26]. 
  Molecular physicochemical and the drug-likeness are the two most significant 
properties to be considered for a compound to become a successful drug candidate. 
It is also important for drug development where a pharmacologically active lead 
structure is optimized step-wise for increased activity and selectivity, as well as drug-





  Nowadays the main objective of these studies is to predict biological activity of 
In-silicodesigned compounds on the basis of already synthesized compounds [28]. 
The molecular modeling and QSAR calculations are used in many fields specially, 
physics, chemistry, biology, material science as well as tissue engineering and drug 
design [29-36].  
  Multiple linear regression (MLR), which is one of the most common and 
simplest method for constructing QSAR models, was used in this study [37 –39]. The 
advantage of MLR is that it is simple to use and the derived models are easy to 
interpret. 
  The useful properties of macrolides range from perfumery to biological and 
medecinal activity. The new finding in the field of antitumour active and other 
antibiotic macrolides, together with pheromones and plant growth regulators with 
macrolactone framework, are an inspiration to chemists to study macrolides. The 
term “macrolide” is used to describe drugs with a macrocyclic lactone ring of 12 or 
more elements. [40] 
  Our work is placed in the context of fundamental and original research on 14- 
membered macrolides and their derivatives, the main objective of this work is the 
application of different methods of molecular modeling to predict the chemical 
reactivity and biological activities expected in new bioactive molecules studied.  
  The structure of the memory, composed by three chapters, has been 
conceptually divided into two differentiated parts. On one hand, the theoretical 
background section, which is composed by chapter 1 and chapter 2. On the other 
hand, chapter 3 and chapter 4 devoted to applications and results, deepens into 
specific practical applications. 
Next, the content of the chapters is briefly described 






  The first chapter is divided into three parts: in the first part, we present 
generalities of the macrolides. In the second part, we will show, on generalities 
regarding Discovery and physicochemical properties of Erythromycin.  The third part 
studies  the ketolides and the structural comparison between the macrolides and the 
ketolides. 
 
❖ CHAPTER 2: Molecular Modeling 
  This chapter contains the main concepts and definitions related to 
computational methods (quantum mechanics methods, Semi - empirical methods 
and molecular mechanics methods). 
 
❖ CHAPTER 3: Geometric, Electronic Structure and Substituent effects of  
                       14- Membered α, β -Unsaturated Macrolides. 
  The third chapter contains a structural, electronic and energetic study of 14- 
membered macrolides and its derivatives. In this chapter we present the results of a 
comparative study on two methods used in the calculation of PM3 and ab initio, as 
well, the substitution effect on energy and electronic parameters of the basic nucleus 
of 14- membered macrolide. 
 
❖ CHAPTER 4:  Drug-likeness properties and Structure activity Relationships of                        
14- Membered  Macrolides. 
 In the last chapter, We highlights the importance of a qualitative study of 
structure-property relationships and drug likeness proprieties of a bioactive series of 
14- membered macrolide derivatives. 
  Finally, we establish a quantitative relationship between physiochemical 
properties and biological activity of a series of bioactive derivatives of 14- membered 
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1. THE MACROLIDES 
1.1 Introduction 
The term macrocycle refers to medium- and large-ring compounds, with, respectively, 
8–11 and 12 or more atoms in the ring. Macrocyclic structures that have one or more ester 
linkages are generally referred to as macrolides or macrocyclic ring lactones. In some cases, 
macrocyclic lactams have also been described as macrolides. Originally macrolides denoted a 
class of antibiotics derived from species of Streptomyces and containing a highly substituted 
macrocyclic lactone ring aglycone with few double bonds and one or more sugars, which 
may be aminosugars, non-nitrogen sugars or both [1]. To our knowledge the largest naturally 
occurring macrolides are the 60-membered quinolidomicins6 and the largest constructed 
macrolide is the 44-membered swinholide [2]. 
In 1927 Kerschbaum isolated the first macrocyclic lactones, Exaltolide®1 and 
ambrettolide 2, from angelica root and ambrette seed oil, respectively [3]. The discovery of 
these vegetable musk oils aroused interest in finding synthesis routes to these and related 
macrolides owing to their commercial importance in the fragrance industry [4].  Even today 
Exaltolide® 3 is one of the most widely produced macrocyclic musk lactones. The production 
was estimated at 200 tons in 1996. The importance of macrocyclic musks is increasing due to 
their ready biodegradability [5]. 
The great breakthrough in macrolide chemistry came in 1950 when Brockmann and 
Henkel isolated the first macrolide antibiotic picromycin 3 from an Actinomyces culture [6]. 
Après les années 1970, la découverte des nouveaux macrolides augmente rapidement. Le 
nombre des macrolides isolés à partir des sources naturelles est environs de 400 composés, 
ce nombre devenu plus de 2000 composés dans les années 2000 [7]. 
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Exaltolide 1 ambrettolide 2 picromycin 3  
Figure 1.1 : chimical Structure of macrolides (1), (2) and (3). 
 
The tremendous interest in macrolide chemistry can be understood if one takes a look 
at the diversity of the structures and physiological effects of macrolides. Natural products 
containing a macrolactone framework are found in plants, insects, and bacteria and they 
may be of terrestrial or marine origin. The useful properties of macrolides range from 
perfumery to biological and medicinal activity. The new findings in the field of antitumour 
active and other antibiotic macrolides, together with pheromones and plant growth 
regulators with macrolactone framework, are an inspiration to chemists to study macrolides 
[1]. 
Macrolide antibiotics play a therapeutically important role. They are regarded as 
among the safest of antibiotics and they have successfully been used to treat infections 
caused by gram-positive organisms and certain gram-negative and anaerobic bacteria. 
Natural macrolide antibiotics can be classified according to the size of the aglycone ring 
[8].The most commonly used macrolide antibiotics, erythromycin and josamycin, belong to 
the groups of 14-membered and 16- membered ring derivatives, respectively [9]. 
1.2. Nomenclature of macrolides 
The nomenclature of macrolides is anything but straightforward. Trivial names are 
widely used, especially for naturally occurring macrocyclic lactones.  
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According to IUPAC rules, macrolides as well as other lactones formed from aliphatic 
acids should be named by adding “olide” as a suffix to the name of the hydrocarbon with the 
same number of carbon atoms. The numbering starts from the ester carbonyl carbon. The 
IUPAC rules also give an alternative way of naming lactones based on the rules for naming 
heterocycles. According to this rule the lactones are named as oxacyclo ketones and the 
numbering starts from the ring oxygen (table 1.1). The AutoNom [10] naming program uses 
this latter rule although the “olide” naming is generally used in the literature. By way of 
example, Figure 1.2 shows the alternative names of two macrolides. The macrolide 
structures of this work are sometimes identified by their trivial names.  
  
                        Undecanolide 
                   Oxacyclododecan-2-one 
          (3Z,11S)-3-Dodecen-11-olide 
          (4Z,12S)-12-Methyl oxacyclododec-4-en-2-one 
          Ferrulactone II (trivial name) 
Figure 1.2  Examples of naming simple macrolides. 
 









Table 1.1  systematic names of selected macrolides 
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The chemistry of macrocyclic compounds originated in 1926 when Ruzicka [11] 
elucidated the structures of civetone 4 and muscone 5 as large-ring ketones ( figure 3). 
Before this time it was believed on the basis of Baeyer’s strain theory [12]  that large-ring 
compounds would be too unstable to exist because the internal bond angles in large planar 
rings do not have tetrahedral geometry. In fact, large rings are able to adopt non-planar 
conformations and they are flexible and almost strain free [4]. 
 
 
civetone 4 muscone 5 
Figure 1.3  structures of civetone  and muscone 
 
1.3 Chemical structure of macrolides and classification  
The macrolides having a monolactone ring can have various ring sizes up to a 62 
membered ring (figure I.5). The macrolides can be classified into four classes : simple 
macrolides, polyenic macrolides, macropolylides and nitrogenous macrolides (azalides). 
The tremendous interest in macrolide chemistry can be understood if one takes a look 
at the diversity of the structures and physiological effects of macrolides. Natural products 
containing a macrolactone framework are found in plants, insects, and bacteria and they 
may be of terrestrial or marine origin. The useful properties of macrolides range from 
perfumery to biological and medicinal activity. The new findings in the field of antitumour 
active and other antibiotic macrolides, together with pheromones and plant growth 
regulators with macrolactone framework, are an inspiration to chemists to study macrolides 
[1] 
Antibacterial agents, or antibiotics, are a class of a much larger group of compounds 
called antimicrobial agents. Antibiotics used to refer to only naturally occurring molecules 
produced by a variety of microorganisms [13]. Macrolides belong to one of the most 
commonly used families of clinically important antibiotics used to treat infections caused by 
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Gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae and 
Streptococcus pyogenes. [14; 15] Chemically, macrolides are represented by a 14-, 15- or 16-
membered lactone ring carrying one or more sugar moieties and additional substitutions 









Figure 1.4: Chemical structures of the 14-, 15- or 16-membered macrolide antibiotics. 
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First row: drugs of the first generation (erythromycin) and second generation (14-
membered ring clarithromycin and 15-membered ring azithromycin). Second row: ketolides, 
the macrolides of the third generation. Third row: examples of 16-membered ring 
macrolides.  The wide variety of macrolide structures in nature can be appreciated just by 
looking at some examples of different types of macrolide antibiotics (Figure 1.5) [16; 17]. 
 
 




c : Nonactin  d : Zearalenone  
  
e : Maytansine  f : Carpaine  
 
 
g : Cytochalasan B  h : Pyrenophorin  
 
Figure 1.5 Examples of macrolide antibiotics: a: polyoxo-macrolide, b: polyene-macrolide , C: 
ionophore-macrolide, d: β-resorcyclic acid macrolides, e: ansamycins , f: alkaloid macrolides, g: 
macrolide cytochalasans, and h: macrotetranolides. 
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1.4 The need for novel antibacterial agents 
The prevalence of drug resistant bacteria is growing at an alarming rate in both 
developing and developed countries [18]. From this statement alone, it should be clear that 
the need for the development of novel antibacterial agents is of utmost importance. In the 
current antibacterial drug pipeline, there is only a miniscule glimmer of hope. This rapid 
increase in resistant bacteria coupled with the slow development of novel agents has lead 
some experts to call this time the “dawn of the post-antibiotic era.” [13] There exists a 
perpetual need for new antibiotics. Most drugs will be just as effective in the future as they 
are today, but that is not the case with antibiotics. Eventually, the inevitable rise of 
resistance will erode the utility of today’s antibiotics. There are three factors that intensify 
this supply problem by discouraging antibiotic development [19].  
First, antibiotics are used in smaller quantities than other drugs. The standard 
antibiotic course lasts only weeks compared to treatment for chronic illness which can last a 
lifetime. Therefore, antibiotics yield lower revenues than most drugs. Second, the use of 
newly approved antibiotics is often limited to serious bacterial infections. The third reason is 
an increase in regulatory requirements to get a drug licensed, which makes clinical trials cost 
prohibitive. However, most newly approved drugs can be prescribed to all who may benefit 
from their use. These factors ultimately result in this quandary: Resistance is on the rise 
while antibiotic discovery and development are on the decline. Having new antibiotics 
approved for use is a great thing, but those antibiotics which utilize the same mechanism of 
action as previously approved drugs always run the risk of increasing the rate of resistance 
[13]. 
 
1.5  Macrolide-binding site in the ribosome 
The discovery of the significance of (hetero) aryl anchored at the terminus of a 
suitable linker enable us design the novel macrolides capable of interacting with a new 
binding site of bacterial ribosome [20]. The general location of the macrolide binding site on 
the large ribosomal subunit has been initially mapped using a combination of biochemical  
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and genetic methods [14]. Nonetheless, the details of the molecular interactions of the 
various classes of macrolides with the ribosome have just started to emerge with the release 
of several crystallographic structures of the archaeal and bacterial large ribosomal subunits 
and their complexes with antibiotics [14]. Because the polar groups locate on the frontal 
face of the aglycone and most of the alkyl groups install on the other face, the two sides of 
the macrolides present hydrophilic and hydrophobic properties, respectively. The 
hydrophobic side is believed to make van der Waals contacts with hydrophobic areas on the 
peptide tunnel wall. Recently, comparison of reduced efficacy of 4,8,10-tridemethyl 
telithromycin and 4,10- didemethyl telithromycin with parent telithromycin undoubtedly 
gave new sight into the important function of these methyl groups [20]. 
A macrolide molecule is coordinated in its binding site by multiple hydrophobic and 
hydrogen bonds (and possibly, a covalent bond in case of some 16-membered ring 
macrolides) between its functional groups and 23S rRNA [14]. These interactions with RNA 
account for most of the free energy of drug binding. In addition, some macrolides can reach 
ribosomal proteins L4 and/or L22. The mucinose sugar of tylosin interacts with L22 and the 
furosamine residue of spiramycin interacts with L4. The proximity of these proteins to the 
macrolide binding site explains why mutations in L22 and L4 protein genes can render cells 
resistant to macrolides [14]. 
 
1.6  Modes of inhibition of protein synthesis by macrolides 
The precise mechanism of protein synthesis inhibition by macrolides depends on the 
specific chemical structure of the drug molecule. This affects its interaction with the 
ribosome as well as the mode of the inhibitory action. Four modes of inhibition of protein 
synthesis have been ascribed to macrolides [14]: 
1) Inhibition of the progression of the nascent peptide chain during early rounds of 
translation [21];  
2) Promotion of peptidyl tRNA dissociation from the ribosome [22]; 
3) Inhibition of peptide bond formation; 
4) Interference with 50S subunit assembly [15].  
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All of these mechanisms have some correlation with the location of the macrolide 
binding site on the ribosome [14]. 
Most macrolides are weak bases and are unstable in acids. The action of macrolides 
can be bactericidal or bacteriostatic, the effect depending on the concentration and the type 
of microorganism targeted by the drug.  
Macrolides bind to the 50S subunit of the bacterial ribosome and inhibit the 
transpeptidation and translocation process, causing premature detachment of incomplete 
polypeptide chains. The antimicrobial spectrum of erythromycin is very similar to penicillin; 
it has proved to be a safe and effective alternative for penicillin-sensitive patients.  
Macrolides are effective against Gram-positive bacteria and spirochetes but not 
against most Gram-negative organisms, the exceptions being Neisseria gonorrhoeae and 
Haemophilus influenzae. Mycoplasma pneumoniae, Legionella species and some chlamydial 
organisms are also susceptible.  
The macrolides are administered orally and intravenously. They diffuse readily into 
most tissues, but do not cross the blood-brain barrier; additionally there is poor penetration 
into synovial fluid. The majority of side effects associated with macrolides are mild and 
transient. As a class they are generally welltolerated. The most common complaints involve 
the gastrointestinal tract and include diarrhea, nausea, vomiting and abdominal pain. 
Patients may complain of an abnormal or metallic aftertaste. Hepatotoxicity is a very rare 
but serious side effect associated with the estolate salt of erythromycin [23]. 
 
1.7 Antibiotic Resistance  
Resistance is defined as the relative insusceptibility of a microorganism to a particular 
treatment under a particular set of circumstances [24]. Some researchers believe that 
resistance is an ecological phenomenon stemming from the response of bacteria to the 
widespread use of antibiotics and their presence in the environment.  
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They believe that the rise in the frequency of antibiotic resistance among pathogens 
should be a “cause of great concern” and suggest “a commitment to act responsibly” [23]. 
 Macrolides inhibit protein synthesis by interacting with bacterial ribosomal RNA. 
Two distinct mechanisms have been responsible for the majority of macrolide resistance 
observed in clinical isolates. The first mechanism involves the production of a ribosomal 
methylase. This enzyme methylates a specific adenine residue on the ribosomal RNA thus 
preventing binding of the macrolide, lincosamide and streptogramin B (MLSB) and conferring 
MLSB resistance. The methylase is the product of a family of genes called erm that can be 
inducibly regulated or constitutively expressed. The second mechanism involves a family of 
genes called mef and is commonly referred to as efflux resistance [25].  
Bacteria resist macrolide and lincosamide antibiotics in 3 ways:  
• Through target-site modification by methylation or mutation that prevents the 
binding of the antibiotic to its ribosomal target, 
•  Through efflux of the antibiotic,  
• And By drug inactivation. These mechanisms have been found in the macrolide and 
lincosamide producers, which often combine several approaches to protect 
themselves against the antimicrobial that they produce. In pathogenic 
microorganisms, the impact of the 3 mechanisms is unequal in terms of incidence 
and of clinical implications [26].  
The extensive use of these antibiotics has led inevitably to the spread of resistant strains. 
Expression of some of the resistance determinants is inducible by macrolides. Of particular 
interest are Erm methyltransferases, which specifically methylate a unique nucleotide within 
the macrolide binding site. The mechanism of Erm induction depends on ribosome stall 
within the translated regulatory open reading frame preceding the Erm cistron, and is 
apparently closely related to the general mode of macrolide action on protein synthesis. 
However, the details of the mechanism of Erm induction are not known [14]. Equally 
important, the study of arising macrolide resistance shed light on how to fight against 
mutation of pathogens [20]. 
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1.7.1  Macrolide action and drug resistance: 
Macrolides inhibit protein synthesis by interacting with bacterial ribosomal RNA. Two 
distinct mechanisms have been responsible for the majority of macrolide resistance 
observed in clinical isolates. The first mechanism involves the production of a ribosomal 
methylase. This enzyme methylates a specific adenine residue on the ribosomal RNA thus 
preventing binding of the macrolide, lincosamide and streptogramin B (MLSB) and conferring 
MLSB resistance. The methylase is the product of a family of genes called erm that can be 
inducibly regulated or constitutively expressed. The second mechanism involves a family of 
genes called mef and is commonly referred to as efflux resistance [25]. 
Bacteria resist macrolide and lincosamide antibiotics in 3 ways: 
(1) Through target-site modification by methylation or mutation that prevents the 
binding of the antibiotic to its ribosomal target,  
(2)  Through efflux of the antibiotic, and  
(3)  By drug inactivation. 
These mechanisms have been found in the macrolide and lincosamide producers, 
which often combine several approaches to protect themselves against the antimicrobial 
that they produce. In pathogenic microorganisms, the impact of the 3 mechanisms is 
unequal in terms of incidence and of clinical implications [26]. 
The extensive use of these antibiotics has led inevitably to the spread of resistant 
strains. Expression of some of the resistance determinants is inducible by macrolides. Of 
particular interest are Erm methyltransferases, which specifically methylate a unique 
nucleotide within the macrolide binding site. The mechanism of Erm induction depends on 
ribosome stall within the translated regulatory open reading frame preceding the Erm 
cistron, and is apparently closely related to the general mode of macrolide action on protein 
synthesis. However, the details of the mechanism of Erm induction are not known [14]. 
Equally important, the study of arising macrolide resistance shed light on how to fight 
against mutation of pathogens [20]. 
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2. Discovery and physicochemical properties of Erythromycin 
2.1 Discovery 
Erythromycin is a macrolide antibiotic, first discovered in 1952. It is produced by an 
actinomycete originally isolated from a soil sample from the island of Panay in the Phillipine 
Archipelago. The actinomycete was identified as a strain of Streptomyces erythreus by 
Waksman and Henrici [27, 28]. The antibiotic, erythromycin, was isolated from this 
actinomycete by McGuire et al in the Lilly Research Laboratories, U.S.A. [29]. 
 
2.2 Chemistry 
Not only does Streptomyces erythreus produce erythromycin (known as 
erythromycin A), it has also been found to produce other antibiotics, namely erythromycin B 
[30]. and erythromycin C [31]. Thus, erythromycin base occurs as a mixture of erythromycin 
A, which is the major component, and smaller amounts of erythromycin B and erythromycin 
C. By means of chromatography and the specific preparative techniques, erythromycin A, B 
or C may be selectively extracted from the mixture [32]. 
The work of a number of authors has lead to the elucidation of the chemical 
structure and stereochemistry of erythromycin [31]. Erythromycin is a polyhydroxylactone 
containing two sugars. The aglycone portion of the molecule is erythranolide, a 14-
membered macrocyclic lactone ring. Attached to the lactone ring, via B-glycosidic linkages 
are two sugars: L-cladinose (2,3,6-trideoxy-3-methoxy-3-C-methyl-L-ribo-hexose), a sugar 
unique to the erythromycin molecule and D-desosamine (3,4,6-trideoxy-3- dimethylamino-
D-xylo-hexose), the portion conferring the basic character to erythromycin, attached at 
positions C3 and C5 respectively [31] The hydroxyl groups at positions ell and C12 are in the 
cis position [31]. Figure 1.6  depicts the chemical structure of erythromycin A and its 
components. 
Erythromycin B differs from erythromycin A by a hydrogen attached to the C9 
position as opposed to the hydroxyl group found in erythromycin A. In erythromycin C the L-
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cladinose sugar found in erythromycin A is replaced by a nonrnethoxylated mycarose [31]. 
Hung, Marks and Tardrew have synthesized erythromycin A, Band C from erythranolide A 
[33]. Figure 1.6 depicts the proposed pathway for the synthesis of erythromycins A, Band C. 
 
 R R1 
Erythromycin A OH CH3 
Erythromycin B H CH3 
Erythromycin C OH H 
Figure 1.6  Chemical structure of erythromycin A and its components 
 
2.3 Physical Properties 
The active form of the drug is erythromycin base. Erythromycin base, 
(C37H67N013.H20, molecular mass = 733.90) is an odourless, bitter-tasting, white crystalline 
compound [34]. It is very slightly soluble in water (2mg/ml) and ether, but is freely soluble in 
alcohols, methanol, acetone, chloroform, acetonitrile and ethyl acetate [31, 34]. A list of 
solubilities of erythromycin are depicted in Table 1.2. 
Whilst there is some controversy over the states of the polymorphic forms of 
erythromycin base, it is generally accepted that erythromycin occurs in a number of 
polymorphic forms: as an amorphous form, a hydrate (both mono- and di-) or as an 
anhydrate crystalline form [35]. In addition, the dihydrate has been shown to exist in three 
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polymorphic forms [36]. However, Bauer et al [37] have Buggested that the so-called mono- 




Petroleum ether 4.69 
CycIohexane 0.2 
Carbon disulfide 5.05 
Carbon tetrachloride >20 
Toluene >20 
Benzene >20 
diethyl ether >20 
Chloroform >20 
Ethylene chloride >20 
Methyl ethyl ketone >20 
Acetone >20 
1,4 -Dioxane >20 
Isoamyl acetate >20 
Ethyl acetate >20 
Isoamyl alcohol 9.65 
Pyridine >20 
Formamide >20 




Ethylene glycol >20 
Water 2.1 
 
Table 1.2 Solubilities of Erythromycin 
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The various polymorphic forms have been reported to affect the solubility of 
erythromycin, with the dihydrate rapidly dissolving whilst the anhydrate is poorly soluble 
due to its hydrophobic nature and poor wettability [35]. Erythromycin base has a melting 
point of between 137°C - 140°C and a specific rotation, [a)250 = - 7PC and - 78° (c = 2' · 
ethanol). The anhydrous base has a melting point of 190°C - 193°C [31]. Erythromycin 
estolate has also been shown to exist in two polymorphic forms: crystalline and amorphous, 
with a slightly crystalline intermediate phase [38]. 
As a result of the N,N-dimethylarnino group, erythromycin has a basic character [31], 
being a relatively weak base with a pka = 8.6 [34]. 
 
2.4 Stability 
It has been well established that erythromycin is unstable in acidic media. Until 
recently, the proposed mechanism of degradation of erythromycin in acidic solutions 
followed one of two pathways depending on the acid conditions. Under mild acid conditions 
(glacial acetic acid) erythromycin enol ether (EEE) is initially formed. Subseguent treatment 
of EEE with acid (methanolic hydrochloric acid) yields anhydroerythromycin (AE). Under 
strong acid conditions (hydrochloric acid) degradation of erythromycin yields only AE. 
Irrespective of the acid strength, no cleavage of the glycosidic linkages has been observed 
[39]. A recent report by Vinckier et al  suggests an alternative mechanism for the acid 
degradation of erythromycin. This alternative mechanism was based on the simple 
observation that when EEE was placed in an acidic solution erythromycin base (EB) was 
formed as a degradation product. Therefore, the new mechanism proposes that the 
degradation of erythromycin is not unidirectional, but rather that there is an equilibrium 
between erythromycin and EEE with a simultaneous pathway by which erythromycin directly 
decomposes to AE without having to pass through EEE [40]. Figure 1.7 represents the 
chemical structures of the acid degradation products of EB, AE and EEE. 
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It has also been established that erythromycin is unstable in strong alkaline solutions, 
with the major degradation product being dihydroerythromycin. As a result of all these 
investigations, it would appear that the pH of maximum stability is between 7 and 8.8 [41], 
although one report has cited the maximum stability to be between pH 6.0 - 9.5 [34]. 
 
 
( I )   6,9 - hemi-acetal of 8,9 - anhydroerythromycin A 
( II )  6,9 - hemi-acetal of 8,9 - anhydroerythromycin B 
( III )   8,9 - anhydroerythromycin A 
 
Figure 1.7 Chemical structures of the acid degradation products of erythromycin base 
Since erythromycin is an acid labile drug, passage through the gastrointestinal tract 
will result in gastric acid inactivation of the drug, causing decreased absorption and low 
serum concentration levels. These problems associated with gastric acid inactivation of the 
drug may be overcome in a number of ways. Firstly, erythromycin base may be protected by 
enteric or film coating of the dosage fornl. This coating protects the drug from the acidic 
environment of the stomach, but allows the release of the active medicament in the more 
favorable environment of the intestine.  
Secondly, the drug may be modified by preparing a salt (stearate), an ester 
(ethylsuccinate (EES) or propionate (PE», or a salt of the ester (estolate (EE) which is the 
lauryl sulphate salt of the propionyl ester and erythromycin acistrate which is the stearic acid 
salt of the 2'- acetyl ester) (38). However, propionyl erythromycin and erythromycin stearate 
have been shown to be unstable in acidic media. When PE is exposed to the acidic solution 
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of the stomach, the carboxylic acid portion is released, leaving behind the soluble 
hydrochloride salt. However, since EE is the salt of a strong acid (lauryl sulphuric acid), unlike 
PE, when it is exposed to the acidic contents of the stomach it does not release the acidic 
portion of the drug and therefore remains insoluble. These salts and esters are also used to 
overcome the bitter taste and water in solubility of erythromycin [43]. Figure 1.8  depicts the 
structural formulae of erythromycin and its most commonly used derivatives. 
 
 R R1 
Erythromycin base H  
Propionyl erythromycin CH2CH2CO  
Erythromycin estotate CH2CH2CO C12H25OSO3 
Erythromycin stearate H C17O35COO 
Erythromycin ethylsuccinate CH2CH2OOCCH2CH2COO  
Erythromycin lactobionate H C11H19O9COO 
Erythromycin glucoheptonate H C6H13O6COO 
 
Figure 1.8  structural  formulae of erythromycin and its most commonly used derivatives 
Not only does pH affect the stability of erythromycin, buffer type and concentration, 
temperature and the presence of metal ions  have also been shown to affect erythromycin 
stability [44,45]. 
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2.5 Erythromycin derivatives  
Recently, new derivatives of erythromycin have been synthesized which inhibit or 
retard the acid degradation process whilst retaining potent antimicrobial activity and 
offering comparative or improved pharmacokinetic properties.  
Modification of the functional groups involved in the degradation mechanism is the 
principle upon which inhibition of the acid degradation of these compounds is based. These 
groups include the ketone at C9, hydroxyl at C6, the proton at C8 and the diol moiety at C11 
and C12. Several modifications have been made to the ketone at the C9 position. The first of 
these modifications, an oximation of the ketone group at C9, resulted in roxithromycin 
(erythromycin, 9-[o-{(2-methoxyethoxy)-methyl}oxime]) .Its acid stability is largely due to 
the inhibition of the internal ketal formation of the aglycone ring (associated with 
erythromycin acid degradation) by the oxime function. The effect of pH on roxithromycin has 
been reported to be similar to that on erythromycin, with roxithrornycin also showing less 
activity at pH = 6 . 5 than at pH = 8.0 [46].  
Another new derivative is dirithromycin (9-deoxo-ll-deoxy-9,11- [imino[2-(2-
methoxyethoxy)ethylidene]-oxy]-(9S)-erythromycin), an oxazine formed from 
erythromycylamine and (2- methoxyethoxy) acetaldehyde. Erythromycylarmine, derived 
from reductive amination of the C9 ketone of erythromycin is no longer considered as an 
acid stable alternative to erythromycin as it yields extremely low blood levels [46]. 
 Dirithromycin, however, achieves sufficiently high concentrations in the blood and 
has a long serum half life. A novel new l5-membered ring compound, azithromycin (a 9- 
deoxo-9a-aza-9a-homoerythromycin A derivative), has been developed as a result of 
modification of the ketone group at position C9 in the erythromycin lactone ring. Utilizing a 
Beckmann rearrangement of the 9-oxime derivative followed by reduction and N-
methylation the I5-membered macrocyclic ring containing a tertiary amino group has been 
synthesized [46].  
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However, a recent report by Fiese and Steffen [47] has shown azithromycin to be 
unstable in aqueous acidic media, although more stable than erythromycin under those 
conditions. Furthermore, unlike erythromycin, there is cleavage of the ether bond resulting 
in the neutral cladinose sugar and a compound CP-66,458 [46]. 
Modification of the hydroxyl group at position C6 (which is involved in the initial 
cyclization step) by means of alkylation has resulted in the formation of 6-0-
methylerythromycin, named clarithromycin [46]. 
  Flurithromycin (S-fluoroerythromycin), synthesized by using both chemical and 
bioconversion methods inhibits acid degradation by preventing the dehydrati on step that 
leads to the formation of the anhydrohemiketal[46]. 
 The various derivatives of erythromycin are depicted in Figures 1.9. Research 
continues on the modification of erythromycin to yield derivatives that will have oral 
efficacy, fewer gastrointestinal side effects and remain acid stable. These modifications 
include reductive amination with aliphatic aldehydes of erythrornycylarnine, formation of 
cyclic 11,12-carbamate derivatives of erythromycin, modification of the hydroxyl group at 
C11 as well as chemical modification of the 11,12-diol moiety and the 4" position [46]. 
 
   
            Roxithromycin            Erythromycylamin                   Dirithromycin 
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                 Azithromycin              Clarithromycin                 Flurithromycin 
 
Figure 1.9  Semisynthetic derivatives of erythromycin 
 
This review is confined to erythromycin and those newer macrolide antibiotics 
synthesized from erythromycin. However, there are a number of other macrolide drugs 
available. These include josamycin, spiramycin as well as the newer semi-synthetic 16-
membered antibiotics rokitamycin and miokamycin. The latter two drugs appear to have 
improved activity against some resistant organisms as well as improved oral bioavailability 
(41). 
  
2.6 Clinical pharmacology 
2.6.1  Spectrum of antimicrobial activity 
Erythromycin is a broad spectrum antibiotic, active against most grampositive and 
some gram-negative bacteria. In addition, it is also effective against Treponema pallidum, 
many strains of rickettsiae and chlamydia and certain non-tuberculosis mycobacteria [48]. 
Although few reports appear in the literature on the antimicrobial spectrum of the new 
semisynthetic macrolide antibiotics, with the possibility of a few exceptions, it is generally 
accepted that they have a very similar antimicrobial spectrum to erythromycin. 
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A list of comparative in vitro activities of erythromycin and five new semisynthetic 
macrolide antibiotics is tabulated in Table 2.2. Although it is evident that there is very little 
or no difference between erythromycin and the newer macrolide antibiotics as far as 
antimicrobial spectrum of activity is concerned, the potentially favourable differences in the 
pharmacokinetic properties (longer half-life, thus having the potential for once-daily dosing) 
of the newer macrolides might make them clinically more advantageous than erythromycin 
[46]. 
 
Table 1.3 Comparative in vitro activities of ERYTHROMYCIN and five new semisynthetic 
macrolide antibiotics 
Microorganism Compound n MIC (µg/ml)    RANGE 






16 0.06 - > 128 
0.12 - > 128 
0.12 - > 128 
0.06 - > 128 
0.03 - > 128 
0.06 - > 128 






13 > 128 
> 128 
128 - > 128 
> 128 
> 128 
128 - > 128 






15 0.06 - > 128 
0.12 - > 128 
0.06 - > 128 
0.06 - > 128 
0.03 - > 128 
0.06 - > 128 






15 0.015 -  0.06 
0.03  – 0.06 
0.03  – 0.12 
0.015 – 0.12 
0.015 – 0.015 
0.03  – 0.06 
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13 ≤ 0.004 - 0. 015 
0.03 – 0.03 
0.03 – 0.06 
≤ 0.004 - 0. 12 
≤ 0.004 - 0. 015 









13 0.015 -  0.12 
≤ 0. 008 -  0.03 
0.06 – 0.25 
0.015 -  0.12 
≤ 0. 008 -  0.03 
0.015 – 0.06 






15 0.06 - > 128 
0.25 - > 128 
0.12 - > 128 
0.25 - > 128 
0.03 - > 128 
0.25 - > 128 






12 0.008 – 16 
0.015 – 32 
0.03 - 64 
0.008 - > 128 
0.008 - 8 
≤ 0. 015 -  32 






14 0.5 – 2 
0.12 – 0.5 
1 – 16 
0.12 – 2 
0.12 – 0.25 
0.5 - 2 
n = number of strains / MS = methicillin sensitive / MR = methicillin resistant 
 
It is evident from Table 2.2 that there is some controversey over the range of 
minimum inhibitory concentrations of erythromycin required to inhibit the growth of various 
microorganisms. 
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2.6.2 Mode of action 
Erythromycin interferes with protein synthesis at the ribosomes. Erythromycin 
penetrates the cell wall of sensitive bacteria and binds to the 50S ribosomal subunit in a 1:1 
stoichiometry. Penetration of the cell wall of sensitive bacteria is dependent on the presence 
of ammonium or potassium salts [49].The exact mechanism by which erythromycin inhibits 
protein synthesis is not known with certainty, but it has been proposed that it inhibits the 
translocation reaction stage of bacterial protein synthesis. Inhibition of translocation is 
primarily due to the detachment of peptidyl-tRNA from the ribosome during translocation 
[50]. 
During translocation, the growing peptide chain moves from the acceptor site to the 
donor thought that erythromycin binds to the translocation of the peptide chain. site on the 
ribosome. It is donor site, thus preventing certain amino acids, in the presence of 
erythromycin, are prevented from being incorporated into polypeptide linkages, but 
erythromycin has no effect on nucleic acid synthesis [51]. 
Although erythromycin acts by inhibiting protein synthesis, it may be bacteriostatic 
or bactericidal depending on the microbial species, sensitivity of the micro-organism, the 
phase of growth of the sensitive pathogen, inoculum density and concentration of 
erythromycin used . At high concentrations of the drug, erythromycin may be bactericidal, 
but at lower concentrations it appears to be bacteriostatic [52]. 
 
2.6.3 Resistance 
There are a number of mechanisms by which pathogens are resistant to 
erythromycin. These include inability of the macrolide to penetrate the cell, chemical 
inactivation of the macrolide and inability of the macrolide to bind to the ribosome target as 
a result of target site modification [53,54]. 
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Conflicting reports appear in the literature with respect to the inability of the 
macrolide to enter the cell. Several reports suggest lack of penetration into the cell causes 
resistance to the macrolide antibiotic. However, other reports indicate that erythromycin 
may enter bacterial cells by means of passive diffusion across the lipid bilayer of the cell 
membrane. Goldman and Kadam, as a result of unpublished observations, suggest that 
further studies in this regard be performed before this mechanism of resistance is generally 
accepted [53]. 
Target site modification, as a result of a number of enzymes which result in mono- or 
di-methylating the N6 amino group of the adenine residue 2058 in 23S rRNA, is the best 
known mechanism of erythromycin resistance . This methylation does not seem to perturb 
ribosomal function, but results in the binding site on the ribosome becoming inaccessible to 
the antibiotic[53]. 
  Resistance due to target site modification may be constitutive (presence of 
erythromycin is not required for resistance), but most frequently it is inducible (resistance to 
erythromycin as a result of the presence of subinhibitory concentrations of the drug) . The 
third mechanism of resistance is inactivation of erythromycin by enzymes produced by the 
micro-organism itself [54]. 
 
2.7 Pharmacokinetics of ERYTHROMYCIN 
Until recently, microbiological assays were the most frequently used technique to 
determine the serum concentrations of erythromycin. Thus, the majority of pharmacokinetic 
parameters for erythromycin have been determined microbiologically [55]. Unfortunately, 
these assays cannot differentiate between parent drug and its metabolites or the free drug 
and its protein-bound or unhydrolysed ester forms. It is thus difficult to compare 
erythromycin bioavailability data from different formulations and from studies using 
different protocols or analytical methods. Similarly, the evaluation of the clinical significance 
of antibiotic concentrations from different dosage forms is also not meaningful [56].  
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Data obtained from bioavailability studies on erythromycin and its derivatives may 
only be compared if the products are assessed under the same conditions [57]. 
 
2.7.1  Absorption and bioavailability 
The free base is the only biologically active in vivo form of erythromycin. The stearate 
and the esters of erythromycin have to dissociate and/or hydrolyse to the free base in vivo in 
order to be biologically active [56]. Studies carried out by Lee et al, in rats, show 
erythromycin to be marginally absorbed from the stomach but extensively absorbed from all 
parts of the small intestine. The authors showed erythromycin to be mainly absorbed in the 
small intestine, with lesser amounts being absorbed in the caecum and large intestine [58]. 
As has been previously mentioned (Section 1.1.4), erythromycin base is unstable in 
acidic media, rapidly degrading to its inactive metabolites, resulting in decreased absorption 
of active drug and thus erratic bioavailability. Erratic bioavailability has been reported with 
film coated (90) and enteric coated erythromycin base tablets [56], whilst better and more 
regular absorption is seen from enteric coated base pellets [59]. Large intersubject variability 
has been reported [60], whilst higher erythromycin serum concentrations have been 
detected in subjects with pernicious anaemia and/or achlorhydria [56]. 
 
2.7.2  Metabolism  
Both erythromycin A and clarithromycin are metabolised through CYP450 3A4. 
However, there are differences in their abilities to bind to and inhibit the cytochrome P450 
isoform CYP 3A4. On the basis of these differences, macrolides (in general) are classified into 
three groups on the basis of data provided by in vitro experiments: 
1) Group 1 include erythromycin A and troleandomycin. Both drugs bind strongly to and 
markedly inhibit CYP 3A4. 
2) Clarithromycin belongs to Group 2 agents. This drug exhibits a lower affinity for CYP 3A4 
compared to erythromycin A, and form complexes to a lesser extent. 
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3) Group 3 include azithromycin and dirithromycin. These compounds have been shown to 
interact poorly with the cytochrome P-450 system in vitro. However, results obtained from 
some clinical studies showed that clarithromycin is similar to erythromycin A in some drug 
interactions (e.g. with psychotropic agents) [61]. 
The emergence and broad spread of resistance prompted the development of the 
new generation of macrolides. Ketolides , representing the third generation, show improved 
potency against many sensitive and some resistant strains and are often associated with 
bactericidal activity. Macrolide antibiotics with an extended macrolactone ring, such as 16-
membered macrolides , find extensive use in veterinary medicine and are sometimes also 
used in humans [62]. 
 
3. THE KETOLIDES 
3.1 Introduction 
  The emergence of antibiotic-resistant bacterial strains is driving the search for new 
antimicrobial agents and will hopefully lead to the widespread application of new antibiotics 
in the future. Within the last 3 years, a number of new agents, such as the newer 
fluoroquinolones and the oxazolidinones, reached the market. They show significantly 
improved activity against bacteria that have acquired resistance or show limited 
susceptibility to older agents [63]. 
Penicillin resistance in pneumococci has already reached alarming levels worldwide 
[64]. Additionally, the lack of activity against atypical pathogens limits the usage of penicillins 
in lower respiratory tract infection. Also the resistance and crossresistance of macrolides, 
which initially offered a good activity against a wide spectrum of respiratory pathogens, is 
increasing among agents of the class [65]. 
 
Macrolides were introduced to the field of anti-infectives, beginning with 
erythromycin A, in the early 1950s [29].  Advantages over existing drugs were their value in 
patients with β-lactam intolerance and activity against penicillin-resistant pathogens. 
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Drawbacks were rapidly evolving resistance, instability of the drug in acid environment, poor 
absorbance by the oral route and gastrointestinal side-effects [66]. New substances ideally 
have activity against key pathogens and overcome resistance problems. A new or extended 
mechanism of action is needed to fulfil these requirements. Telithromycin (HMR 3647) is the 
first antibiotic belonging to a new class of 14-membered ring macrolides, named ketolides, 
to reach clinical use. This new addition to the macrolide–lincosamide–streptogramin B 
(MLSB) group was developed specifically for the treatment of community acquired 
respiratory tract infections. Telithromycin was developed at Aventis (Romainville, France) 
and reached the market (Germany and Spain) as Ketek late in 2001 [67]. 
 
3.2   From macrolides to ketolides (Chemistry and structure–activity 
relationship). 
The structural characteristics responsible for this property are (Figure 1.10) [68]:  
i) removal of the cladinose normally present at position 3 and its replacement by a 
keto-group (hence the name ketolides); 
ii)  incorporation of an 11,12- or 6,11-cyclic moiety 
iii)  addition of a heteroaryl-alkyl side chain attached to the macrocyclic ring by a 
suitable linker. 
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Figure 1.10 Chemical structure of telithromycin; (a) the methoxy-group at C6 improves acid stability 
and prevents internal hemiketalization; (b) 3- keto-function avoids MLSB resistance induction and improves 
ribosome binding; (c) C11/12 carbamate side-chain increases affinity for the ribosomes and improves 
interaction with MLSB-resistant ribosomes. 
 
The L-cladinose sugar was long thought to be essential for the antimicrobial activity 
of the 14-membered ring macrolides, since its removal from clarithromycin, azithromycin 
and roxithromycin leads to loss of antimicrobial activity. However, with the ketolides, 
modifications at other positions of the macrolactone ring compensate the loss of cladinose 
(C3, C6, C11/12) [69]. Telithromycin is differentiated from other known ketolides by the 
introduction of a large aromatic N-substituted carbamate extension at position C11–C12.   
This ring also has an imidazo-pyridyl group attachment. Telithromycin possesses a 6-OCH3 
group (like clarithromycin), avoiding internal hemiketalization with the 3-keto function and 
giving the ketolide molecule excellent acid stability [70].  
Like erythromycin, roxithromycin, clarithromycin and azithromycin, the ketolides 
belong to the MLSB group of antimicrobials [67]. 
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3.3 Mechanism of action 
MLSB antimicrobials target the bacterial ribosomes, which consist of two subunits, 
30S and 50S. The two subunits are made of ribosomal RNA (rRNA) and numerous protein (r-
protein) components. The 30S ribosomal subunit interacts with the messenger RNA (mRNA) 
and translates in conjunction with transfer RNAs (tRNAs) the genetic code on the mRNA. The 
large subunit (50S) provides the catalytic centre (peptidyl transferase centre) where a 
peptide bond is formed between the amino acid and the peptide chain previously 
synthesized. The growing peptide passes through a peptide exit channel within the 50S 
subunit to emerge on the back of the ribosome [69]. 
Ketolides inhibit the synthesis of new proteins by preventing the bacterial ribosome from 
translating its mRNA. This process is blocked in two different ways.  
(1) The peptidyl transferase centre in the 50S subunit is the site of interaction of MLSB 
antibiotics and of chloramphenicol and puromycin. The structure of the 50S subunit 
has recently been resolved by visualizing molecular details at atomic resolution using 
X-ray crystallography. The peptidyl transferase centre appears to be constructed 
entirely from elements of 23S rRNA, which is composed of six domains. This indicates 
that peptide bonds are catalysed by rRNA and that the catalytic centre is formed 
mainly from structures in domain V of the 23S rRNA. MLSB drugs, such as 
chloramphenicol and puromycin, bind to closely related sites on the 50S ribosomal 
subunit and interact with an internal loop structure within domain V of bacterial 23S 
rRNA in the upper portion of the peptide exit channel close to the peptidyl transferase 
centre (figure 1.11) [69,71].   
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Figure 1.11 Secondary structure models of the peptidyl transferase centre in domain 
V of 23S rRNA (a) and hairpin 35 in domain II (b) Positions of macrolide interactions and of 
mutations that confer macrolide resistance are indicated and nucleotides are circled, respectively. 
Ery, erythromycin; Cbm, carbomycin; Tyl, tylosin; Tel, telithromycin [72]. 
 
Macrolides and ketolides bind to the same region of 23S rRNA. Because of the 
C11/12 carbamate arm in ketolide antimicrobials, the strength of interaction is different 
from those of macrolides. The drugs bind to the ribosome and interact with specific 
nucleotides in the rRNA, preventing these nucleotides from reacting with chemical reagents 
[69,71].    
The drug-binding sites in hairpin 35 of domain II and the peptidyl transferase loop of 
domain V of the 23S rRNA are folded close to each other, forming a binding pocket for 
macrolides and other drug types [69,71].  
The alkyl–aryl extension at C11–C12 in the ketolide lactone ring produces the 
dominant effect in protecting position A752 in hairpin 35 of domain II. The cladinose moiety 
influences this position by expressing a less strong binding. The binding affinity for 
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telithromycin evaluated as dissociation constants is ∼10-fold stronger than that for 
erythromycin [71]. 
 Hairpin 35 and the peptidyl transferase loop act as a single drug-binding site on the 
ribosome, binding one ketolide molecule [69,71].The distance between the nucleotides 
involved in drug binding is probably spanned by the C11/12 carbamate compounds, whereas 
erythromycin and clarithromycin might not be capable of making direct contact with the 
base of A752 [69]. 
(2) The numerous r-protein components of rRNAs are required to create the two subunits 
of newly formatted ribosomes. Some 34 r-proteins and two rRNA molecules (5S and 
23S) form a functionally active 50S subunit. Macrolides and ketolides interact with 
partially assembled 50S subunit precursors to block this process, leading to nucleolytic 
degradation of the unassembled precursor particles. In cells treated with 
erythromycin, a 50S precursor particle accumulates. Erythromycin is bound by this 
particle that contains 23S and 5S rRNAs but only 18 of the 34 large subunit r-proteins. 
Cellular ribonucleases degrade the unassembled 50S subunit particle[69]. 
 
3.4 Antibacterial activity  
The microbiological profile of telithromycin is characterized by high in vitro activity 
against many common and atypical/ intracellular respiratory pathogens, including MLSB-
resistant strains [67]. 
  Telithromycin has improved in vitro activity against Gram-positive aerobes 
compared with macrolides and azalides. High activity of telithromycin against atypical 
respiratory pathogens (Bordetella spp., Legionella spp., Chlamydia pneumoniae, 
Mycoplasma pneumoniae) was demonstrated [73,74]. Its potency against key community-
acquired Gram-negative respiratory pathogens such as Moraxella catarrhalis and 
Haemophilus influenzae appeared similar to that of azithromycin [75,76].  
Telithromycin was found to be active against several Gram-positive and -negative 
anaerobic bacteria such as Clostridium spp., Peptostreptococcus spp. and Bacteroides spp 
[77]. Telithromycin is inactive against Enterobacteriaceae, nonfermentative Gram-negative 
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bacilli, Acinetobacter baumanii and constitutively MLSB-resistant Staphylococcus aureus. In 
a study from Spain, telithromycin displayed significant in vitro activity against Streptococcus 
pneumoniae isolates regardless of the presence of different macrolide resistance 
determinants [erm(B), mef(A)] [78]. Telithromycin is two to five times more active than 
clarithromycin against Gram-positive cocci susceptible to erythromycin A. Telithromycin is 
bactericidal against S. pneumonia [79]. 
 
3.5 Resistance 
Three main mechanisms of resistance account for acquired resistance to MLSB 
antimicrobials: 
 (i) target site modification, (ii) reduced intracellular accumulation due to decreased 
influx or increased efflux of the drug and (iii) production of inactivating enzymes. 
(i) Target site modification 
Target site modification occurs as a mutation on 23S rRNA or on ribosomal proteins, 
or is due to mono- or dimethylation of 23S rRNA at positions A2058 and A2059. Methylation 
is usually governed by the acquisition of erm genes. erm genes encode methyltransferases 
that N6-dimethylate specific adenine residues within a conserved region of the rRNA. 
Ribosomal methylation confers cross-resistance to MLSB antibiotics because the binding 
sites of these drugs overlap. The methylation leads to a conformational change in the 
ribosome, resulting in decreased affinity for all MLSB antibiotics. Numerous erm genes have 
been described for different clinically important bacterial species [80]. Methylation or 
substitution of A2058 alters the major contact site for the drugs. Binding of clarithromycin 
and erythromycin to Escherichia coli ribosomes is reduced over 10000-fold by the 23S rRNA 
A2058G mutation. Binding of telithromycin is reduced by the A2058G mutation, but this 
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(ii) Efflux pumps 
 Efflux pumps for erythromycin A have been described for several Gram-positive 
cocci. The efflux-mediated resistance pattern, known as M phenotype, is encoded by 
different genes: mef (A) or mef (E) in streptococci, and msr(A) and msr(B) in 
staphylococci[78]. The phenotype of macrolide resistance in S. pyogenes is differentiated by 
the so-called double- or triple-disc assay [81]. The conventional double-disc assay uses 
erythromycin and clindamycin to identify strains expressing the M phenotype, which is 
characterized by susceptibility to lincosamides, even after induction, and 16-membered 
macrolides. This resistance pattern has also been observed in S. pneumoniae [82]. 
(iii) Production of antibiotic inactivating enzymes  
Degradation due to hydrolysis of the macrolide lactone ring by an esterase and 
modification due to macrolide phosphorylation and lincosamide nucleotidylation appear to 
play a minor role in MLSB resistance. Only a few strains have been reported to harbour 
corresponding genes and to produce inactivating enzymes [83]. 
 
3.6 Stability 
Ketolides are highly stable in acidic media. The C11–C12 carbamate substituent is 
responsible for improved activity in comparison with erythromycin A. Differences in the side 
chains fixed to the C11–C12 carbamate residues characterize numerous carbamate ketolides 
such as HMR 3004, ABT 773 and telithromycin [84]. In addition, the C11–C12 fixed side chain 
defines in vitro activities, pharmacodynamics, intracellular uptake, accumulation and efflux, 
and tolerance[85]. 
Namour et al. [86] evaluated the single- and multiple-dose pharmacokinetics and 
dose proportionality of telithromycin given once daily over the dose range of 400–1600 
mg/day in healthy human subjects. Absorbance after oral administration was rapid, reaching 
Cmax within 1 h of dosing.  
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Food intake did not affect absorption. Steady-state plasma concentrations were 
reached within 2–3 days of multiple dosing, regardless of the dose. Total plasma protein 
binding was ∼70% with an absolute bioavailability of telithromycin of 57%. 
 
3.7 Metabolism and drug interaction 
Telithromycin undergoes hepatic metabolization and is eliminated primarily through 
the faeces (∼80%)[86]. RU 76363, an alcohol resulting from hydrolysis of the aryl rings of the 
carbamate side chain of telithromycin, is the major hepatic metabolite, and is 4- to 16-fold 
less active than telithromycin in vitro. Its AUC represents ∼10–12% that of telithromycin 
[85]. Excretion of telithromycin is almost complete in urine after 24 h and in faeces after 72 
h [87]. 
Telithromycin is an inhibitor of CYP3A4 and in vitro of CYP2D6. Telithromycin should 
not be used in combination with drugs such as simvastatin, midazolam and cisaprid. Plasma 
concentrations of cyclosporin, tacrolimus and sirolimus need to be monitored during 
telithromycin therapy. An increase in QTc interval (< 500 ms) in special patients has been 
described [85]. The increase in the AUC of telithromycin due to therapy with itraconazole 
and ketoconazole does not indicate a dose adjustment. AUCs of theophylline, digoxin and 
levonorgestrel are increased in the presence of telithromycin [88]. 
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In recent decades, computer simulation has become an important tool in various 
fields such as mechanical engineering, chemistry, physics and materials [1-3]. In particular, 
computer simulations that take account of electronic structures [4]. 
At the present time, the computer simulation is one of the main tools to identify the 
regularities of behavior of the molecular systems under various external influences. [5] 
Molecular modeling is the computer simulation of molecular structures, which 
concerns the distances and angles of bonds in chemical molecules, also the results of 
introduction and substitution of atoms or groups of atoms in the molecule.  
Molecular modeling is the sum of theoretical methods and computational techniques 
that is used to predict molecular behaviours specifically interactions between molecules. [6] 
Molecular modeling has been introduced as a valuable methodology for scientific 
research providing useful tools for the analysis and estimate of the physicochemical 
parameters and/or biological activity. [7] 
Molecular modeling can be considered as a range of computerized techniques based 
on theoretical chemistry methods and experimental data that can be used either to analyze 
molecules and molecular systems or to predict molecular, chemical, and biochemical 
properties [8-10]. It serves as a bridge between theory and experiment to: 
1. Extract results for a particular model. 
2. Compare experimental results of the system. 
3. Compare theoretical predictions for the model. 
4. Help understanding and interpreting experimental observations. 
5. Correlate between microscopic details at atomic and molecular level and macroscopic 
properties. 
6. Provide information not available from real experiments. 




All molecular calculation techniques can be classified under three general categories: 
➢ ab initio and density functional electronic structure calculations,  
➢ semi-empirical methods, and 
➢ Molecular Mechanics 
 
2. Quantum Mechanical Methods 
2.1 Schrödinger equation 
The starting point of the following overview is the Schrödinger equation [11 - 14] in 







 Ĥ𝚿                     (𝟏) 
 
Ĥ 𝜳 =  𝑬𝜳                        (𝟐) 
 
where the wave functions Ψ and Ψ are functions of all coordinates of the relevant system 
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where I and J refer to the nuclei i and j refer to electrons. The first term in (3) is the operator 
of the kinetic energyof the nuclei. The second term is the operator of the kinetic energy of 
the electrons. The third term is the potential energy of repulsions between the nuclei, 𝑟𝐼𝐽 is 
the distance between the nuclei I and J with atomic numbers ZI and ZJ. The fourth term is the 
potential energy of the attractions between the electrons and the nuclei and 𝑟𝑖𝐼is the 




distance between electron i and nucleus I. The last term is the potential energy of the 
repulsions between the electrons, rij is the distance between electrons i and  j . 
  
2.2 The Born-Oppenheimer Approximations:  
simplifies the general molecular problem by separating nuclear and electronic 
motions. This approximation is reasonable since the mass of a typical nucleus is thousands of 
times greater than that of an electron. The nuclei move really slowly with  respect to the 
electrons. Thus, the electronic motion can be described as occurring in a field of fixed nuclei. 
We can use the Born-Oppenheimer approximation to construct an electronic Hamiltonian, 
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This Hamiltonian is used in the Schrödinger equation describing the motion of the electrons 
in the field of the fixed nuclei: 
Ĥ𝒆𝒍𝒆𝒄𝜳𝒆𝒍𝒆𝒄 =  𝑬𝒆𝒇𝒇 𝜳𝒆𝒍𝒆𝒄                             (𝟓) 
Solving this equation for the electronic wave function will produce the effective-nuclear 
potential function Eeff that depends on the nuclear coordinates and describes  
the potential energy surface of the system. For bond electronic problem,  𝛹 should satisfy 
two requirements: antisymmetricity and normalization.  𝛹 should change sign when two 
electrons of the molecule interchange and the integral of  𝛹 over all space should be equal 









3. Hartree-Fock Self-Consistent Field Method 
Much of the difficulty of solving the Schrödinger equation stems from the need to 
simultaneously determine the energy of eachelectron in the presence all other electrons. In 
the Hartree-Fock (HF) method this is avoided by calculating the energy of each electron in 
the averaged staticfield of the others. Initially a guess is made of the electron energies.  
The energy of each electron is then calculated in the field of the initial electron 
configuration. This procedure is repeated in an iterative loop until convergence (Self-
Consistent referring to this iterative calculation).  
The Hartree-Fock method can therefore be thought of as a kind of mean-spherical 
approximation at the electron level. The difference between the Hartree-Fock energy and 
the energy for the full Schrödinger equation is called the correlation energy. Hartree-Fock 
calculations are sufficiently accurate to provide insight into many problems and they are 
widely used. As Hartree-Fock calculations have been applied to different problems it has 
however become increasingly clear that the correlation energy is of great significance in 
determining the properties of a system. Efforts have therefore been made to improve on the 
Hartee-Fock energy. 
 
3.1 Post-HF Methods 
There a number of different methods that go beyond Hartree-Fock calculations, one 
of the widely used approaches is perturbation theory. In perturbation theory the Hartree-
Fock solution is treated as the first term in a Taylor series. Theperturbation terms added 
involve the electron repulsion. One of the more common forms was developed by Møller 
and Plesset.The second order perturbation form is referred to as MP2. This form will be 
utilized in the present work.  
It should be noted that the electron-electron repulsion energy is not necessarily a 
small perturbation. In cases in which this term is large the application of perturbation theory 
can become more difficult.  




There are a number of other techniques to include electron correlation that can 
potentially provide very accurate results, such calculations can however become very time 
consuming and at present they tend to be used for small molecules with maybe 3-4 heavy 
(non-hydrogen) atoms. The molecules studied in the present work are somewhat larger and 
the decision has been made not to use such time-consuming methods. 
 
3.2 Moller-Plesset perturbation theory (MP) 
The Moller-Plesset (MP) Perturbation Theory attempts to correct the HF theory, 
which as mentioned earlier provides an approximation for the repulsion term between 
electrons and determines the position of an electron solely with respect to the atom’s nu-
cleus and the average of other electrons. As this model is not quite accurate, the MP theory 
uses HF as a starting point and then corrects it for the attraction term between the nucleus 
and the electron as well as the position of an electron with respect to another electron.  
The number following MP, such as MP2 or MP3, indicates the number of 
perturbations, or approximation terms, used in the theory. Generally, the higher this 
number, the greater the accuracy of the method. 
 
3.3 Density-Functional Theory (DFT) 
DFT theory models electron correlation as a functional of the electron density, ρ. The 
functional employed by current DFT methods partitions the electronic energy via the Kohn-
Sham equations [9, 10] into several terms : 
𝑬 = 𝑬𝑻 + 𝑬𝑽 + 𝑬𝑱 + 𝑬𝑿𝑪                         (6) 
 
where 𝐸𝑇 is the kinetic energy term (arising from the motion of the electrons), 𝐸𝑉 is the 
potential energy term that includes nuclear-electron and nuclear-nuclear interactions, 𝐸𝐽 is 
the electron-electron repulsion term and 𝐸𝑋𝐶  is the electron correlation term. All terms 
except nuclear-nuclear repulsions are functions of the electron density.  





The terms 𝐸𝑇 + 𝐸𝑉 + 𝐸𝐽 represent the classical energy of the electron distribution, while 
𝐸𝑋𝐶  represents both the quantum mechanical exchange energy, which accounts for electron 
spin, and the dynamic correlation energy due to the concerted motion of individual 
electrons. 
Pure DFT methods calculate 𝐸𝑋𝐶  by pairing an exchange functional with a correlation 
functional and so are designated by the choice of combination. For example, BLYP combines 
Becke’s gradient-corrected exchange functional with the gradient-corrected correlation 
functional of Lee, Yang and Parr [15]. 
DFT calculations fall into three general categories: local density approximations 
(LDA), generalised gradient approximations (GGA), and ʺhybridʺ combinations of DFT and 
Hartree-Fock terms. LDA exchange and correlation functionals only contain terms related to 
electron density- an approach that works for some bulk materials, but fails to accurately 
predict properties in isolated molecules. GGA (ʺnonlocalʺ) functionals contain terms that 
depend upon both the electron density and the density gradients. 
The gradient-corrected density functional method BLYP is capable of predicting 
intramolecular bond dissociation energies to within a few kJ/mol [16]. However, the 
generalised gradient approximation severely underestimates activation barriers for some 
reactions due to neglect of Coulomb ʺself-interactionʺ of the electrons [17].  
This problem is remedied with hybrid methods that combine Hartree-Fock self-
interaction corrections with density functional exchange and correlation. Examples of hybrid 
methods are B3LYP and B3PW91, where B3 denotes Becke’s three-parameter hybrid 
functional [18,19], while‘PW91’ and ‘LYP’ are gradient-corrected correlation functionals of 
Perdew and Wang [20] and, as above, Lee, Yang and Parr. 
 
3.4 Quantum methods: Ab initio : 
Having established the importance of the electronic wave function (ψ) in Eq. (2), it is 
now necessary to discuss the methods that enable the derivation of the electronic states for 




which Eq. (2) holds true, the following discussion is an outline of the fundamentals of 
Hartree–Fock theory from which both semi-empirical and density functional methods have 
been developed [21]. In this theory, the wave function [22], is considered as a series of 
molecular orbitals, which are occupied by electrons. One of these sets of molecular orbitals 
will correspond to the ground state and hence have the lowest energy. [21] 
Ab initio methods are derived from theoretical principles, with no inclusion of 
experimental data, it take account both, electron and core in treatment. 
practical ab initio calculations are severely limited by the types of atoms and size of 
molecules. [23]. these calculations are really time consuming and need large CPU memories. 
 
4. Semi-empirical method 
Most molecular computations done by organic chemists, especially those examining 
minimum energy geometries, are done using this method because it provides the best 
compromise between speed and accuracy.  This method can be thought of as a hybrid of 
molecular mechanics-type models based on experimentally measured empirical data and 
pure theory quantum chemical, thus the name semi-empirical.  It uses the Schrödinger 
equation approximations, but in order to make the calculations less time-consuming, it only 
calculates the locations of valence electrons, not all electrons. For the inner shell electrons, 
empirical data from typical organic molecules is used to estimate their locations. 
The semi empirical methods are presented by : 
 
❖ MNDO method (Modified Neglect of Diatomic Overlap) [24] which takes in 
account the repellencies between the electrons pairs and the electron-electron perellence 
directions; 
 
❖ ZDO method (zerodifferential overlap) is based on the Huckel method for the π 
electrons; 
 




❖ CNDO method (Complete Neglect of Differential Overlap) which takes inaccount 
only the atomic orbital of spherical symmetry and assesses therepellence integrals as the 
orbital would be sphere. In this case are two methodsCNDO/1 and CNDO/2 which are used 
for the spectrum parameters; 
 
❖ INDO method [25] (Intermediate Neglect of Differential Overlap) which includes the 
monoelectronic repellence integrals between atomic orbital of the same atom;  
 
❖ NDDO method (Neglect of Differential diatomic orvelap) which takes in account 
the orientation direction of the orbital; MINDO/3 [26] method is an particular case of the 
NNDO method which assesses the monoelectronic repellence integrals;  
 
❖ SAM1 (Semi-Ab-Initio Model 1) 
The final 1993 offering in Michael Dewar’s name was Semi-Ab-Initio Model 1 [27]. 
In SAM1, two-electron integrals are calculated using a standard STO-3G basis set (and hence 
the appearance ofab initioin the title). The resulting integrals were then scaled, and the 
Gaussian terms in the core–core repulsions were retained in order to fine-tune the 
calculations. 
 
❖ AM1 (Austin Model 1) 
Next came Austin model 1 (AM1), due to M. J. S. Dewar et al. [28]. AM1 was designed to 
eliminate the problems from MNDO caused by a tendency to overestimate repulsions 
between atoms separated by the sum of their van der Waals radii. The strategy adopted was 
to modify the core–core terms by multiplication of the Coulomb term with sums of Gaussian 
functions.  
In the original AM1 paper there are four terms in the Gaussian expansion. Each 
Gaussian is characterized by its position along the A–B vector and by its width. This 
significantly increased the number of parameters for each atom. 




The performances of the semi empirical method consist in the smaller cost of them and it 
their speed, but also in the fact they can determine some properties that can not be 
established experimentally. 
 
❖ PM3 (parameterized method 3) 
PM3 is the third parameterization of MNDO, and the PM3 model contains essentiallyall the 
same terms as AM1. The parameters for PM3 were derived by J. J. P. Stewart [29] in a more 
systematic way than for AM1, many of which were derived by ‘chemical intuition’. As a 
consequence, some of the parameters are quite different from those of MNDO but the two 
models seem to predict physical properties to the same degree of accuracy. 
 
5. Molecular Mechanics (MM) 
Molecular mechanics describes molecules in terms of “bonded atoms”, which have 
been distorted from some idealized geometry due to non-bonded van der Waals and 
Coulombic interactions. [30, 31] 
Molecular mechanics calculates the energy of a molecule and then adjusts the energy 
through changes in bond lengths and angles to obtain the minimum energy structure. 
Molecular mechanics models are useful in studying structures, conformational 
energies and other molecular properties, including vibrational frequencies, conformational 
entropies and dipole moments, etc. [32]. 
5.1 Steric Energy 
A molecule can possess different kinds of energy such as bond and thermal energy. 
Molecular mechanics calculates the steric energy of a molecule (the energy due to the 
geometry or conformation of a molecule). Energy is minimized in nature, and the 
conformation of a molecule that is favored is the lowest energy conformation. Knowledge of 
the conformation of a molecule is important because the structure of a molecule often has a 
great effect on its reactivity. The effect of structure on reactivity is important for large 




molecules like proteins. Studies of the conformation of proteins are difficult and therefore 
interesting, because their size makes many different conformations possible.  
Molecular mechanics assumes the steric energy ofa molecule to arise from a few, 
specific interactions within a molecule. These interactions include the stretching or 
compressing of bonds beyond their equilibrium lengths and angles, torsional effects of 
twisting about single bonds, the Van der Waals attractions or repulsions of atoms that come 
close together, and the electrostatic interactions between partial charges in a molecule due 
to polar bonds. To quantify the contribution of each, these interactions can be modeled by a 
potential function that gives the energy of the interaction as a function of distance, angle, or 
charge [30,33]. 
The total steric energy of a molecule can be written as a sum of the energies of the 
interaction: 
𝑬𝒔𝒕𝒆𝒓𝒊𝒄 𝒆𝒏𝒆𝒓𝒈𝒚 =  𝑬𝒔𝒕𝒓 + 𝑬𝒃𝒆𝒏𝒅  +  𝑬𝒕𝒐𝒓  +  𝑬𝑽𝒅𝑾 + 𝑬𝒒𝒒                    (𝟕) 
 
The bond stretching, bending and torsion interactions are called bonded interactions 
because the atoms involved must be directly bonded or bonded to a common atom. The Van 
der Waals and electrostatic (qq) interactions are between non-bonded atoms. 
 
𝑬𝒔𝒕𝒆𝒓𝒊𝒄 𝒆𝒏𝒆𝒓𝒈𝒚 = 𝑬𝒕𝒐𝒕
= ∑ 𝒌𝒓(𝒓 − 𝒓𝒆𝒒)
𝟐
𝒃𝒐𝒏𝒅𝒔























































 (𝟏𝟑)  
 
5.2 Examples of MM force fields :In Common use are: 
✓ AMBER  
(Assisted Model Building with Energy Refinement) - primarily designed forthe study of 
biomolecules such as proteins and nucleotides [34]. 
 
✓ CHARMM  
(Chemistry at HARvard Molecular Mechanics) - primarily designed for biological and 
pharmaceutical study, but has also been applied to micelles and self-assembling 
macromolecules [35]. 
✓ MMx (MM2, MM3, etc)  
 Optimised for structural and thermodynamic studies of small non-polar molecules [47]. 
MMx force fields include third- and fourth-order corrections to standard quadratic fits for 




the potential energy surfaces of bonds and bond angles, thus allowing for non-harmonic 
effects in molecular vibrations. The various MMx versions differ primarily in their 
parameterisations. The higher versions tend to be more modern and address deficiencies in 
their predecessors. However, for the newer versions such as MM4, parameters may not be 
available for all classes of molecules. 
 
✓ OPLS 
(Optimised Potentials for Liquid Simulations)-optimised for reproducing the physical 
properties of biomolecules in liquid solutions [36]. 
The authors are not aware of any published study discussing the use of AMBER, 
CHARMM, MMx or OPLS with energetic materials. Since these packages are optimised for 
biochemistry and pharmaceutical applications, it is unlikely that they will accurately 
reproduce the behaviour of energetic materials without further modification. However, it is 
likely they can be used for limited applications with only slight modification. 
 
✓ CFF 
The consistent force field (CFF) [37-40] was developed to yield consistent accuracy of results 
for conformations, vibrational spectra, strain energy, and vibrational enthalpy of proteins. 
There are several variations on this, such as the Ure-Bradley version (UBCFF), a valence 
version (CVFF), and Lynghy CFF. The quantum mechanically parameterized force field 
(QMFF) was parameterized From ab initio results. CFF93 is a rescaling of QMFF to reproduce 
experimental results. These force fields use five to six valence terms, one of which is an 
electrostatic term, and four to six cross terms. 
✓ DREIDING [41] 
DREIDING is an all-purpose organic or bio-organic molecule force field. It has been most 
widely used for large biomolecular systems. It uses five valence terms, one of which is an 
electrostatic term. The use of DREIDING has been dwindling with the introduction of 
improved methods. 





The Merck molecular force field (MMFF) is one of the more recently published force fields in 
the literature. It is a general-purpose method, particularly popular for organic molecules. 
MMFF94 [42] was originally intended for molecular dynamics simulations, but has also seen 
much use for geometry optimization. It uses five valence terms, one of which is an 
electrostatic term, and one cross term. 
 
✓ MOMEC 
MOMEC [40] is a force field for describing transition metal coordination compounds. It was 
originally parameterized to use four valence terms, but not an electrostatic term. The metal-
ligand interactions consist of a bond-stretch term only. The coordination sphere is 
maintained by non bond interactions between ligands. MOMEC generally works reasonably 
well for octahedrally coordinated compounds. 
 
✓ GROMOS  
(Groningen Molecular Simulation) developed at the University of Groningen and  the ETH 
(Eidgenössische Technische Hochschule) of Zurich [41] is quite popular for predicting the 
dynamical motion of molecules and bulk liquids, also being used for modelling biomolecules. 
It uses five valence terms, one of which is electrostatic [45]. Its parameters are currently 
being updated [46]. 
 
5.3 Energy Minimization and Geometry Optimization 
The basic task in the computational portion of MM is to minimize the strain energyof the 
molecule by altering the atomic positions to optimal geometry. This meansminimizing the 
total nonlinear strain energy represented by the force field equation with respect to the 
independent variables, which are the Cartesian coordinates of the atoms [47]. The following 
issues are related to the energy minimization of a molecular structure: 




• The most stable configuration of a molecule can be found by minimizing its free 
energy, G. 
• Typically, the energy E is minimized by assuming the entropy effect can be neglected. 
• At a minimum of the potential energy surface, the net force on each atom vanishes, 
therefor the stable configuration. 
Because the energy zero is arbitrary, the calculated energy is relative. It is meaningful only to 
compare energies calculated for different configurations of chemically identical systems. 
• It is difficult to determine if a particular minimum is the global minimum, which is the 
lowest energy point where force is zero and second derivative matrix is positive definite. 
Local minimum results from the net zero forces and positive definite second derivative 
matrix, and saddle point results from the net zero forces and at least one negative 
eigenvalue of the second derivative matrix. 
 
6 Research Methods of Global Minimum 
The most widely used methods fall into two general categories: 
(1) steepest descent and related methods such as conjugate gradient, which use first 
derivatives, and 
(2) Newton Raphson procedures, which additionally use second derivatives. 
 
6.1 The Steepest Descent Method : [48] depends on: 
1- either calculating or estimating the first derivative of the strain energy with respect to 
each coordinate of each atom and 
2- moving the atoms.  
The derivative is estimated for each coordinate of each atom by incrementally 
moving the atom and storing the resultant strain energy change. The atom is then returned 
to its original position, and the same calculation is repeated for the next atom. After all the 
atoms have been tested, their positions are all changed by a distance proportional to the 
derivative calculated instep 1. The entire cycle is then repeated. The calculation is 




terminated when the energy is reduced to an acceptable level. The main problem with the 
steepest descent method is that of determining the appropriate step size for atom 
movement during the derivative estimation steps and the atom movement steps. The sizes 
of these increments determine the efficiency of minimization and the quality of the result. 
An advantage of the first-derivative methods is the relative ease with which the force field 
can be changed. 
6.2 The Conjugate Gradient Method :  
is a first-order minimization technique. It uses both the current gradient and the previous 
search direction to drive the minimization. Because the conjugated gradient method uses 
the minimization history to calculate the search direction and contains a scaling factor for 
determining step size, the method converges faster and makes the step sizes optimal as 
compared to the steepest descent technique.  
However, the number of computing cycles required for a conjugated gradient calculation is 
approximately proportional to the number of atoms (N), and the time per cycle is 
proportional to N. 
The Fletcher-Reeves approach chooses a descent direction to lower energy by 
considering the current gradient, its conjugate, and the gradient for the previous step. The 
Polak- Ribiere algorithm improves on the Fletcher-Reeves approach by additional 
consideration of the previous conjugate and tends to converge more quickly. 
 
6.3 The Newton-Raphson Methods : of energy minimization [30] utilize the 
curvature of the strain energy surface to locate minima. The computations are considerably 
more complex than the first-derivative methods, but they utilize the available information 
more fully and therefore converge more quickly. These methods involve setting up a system 
of simultaneous equations of size(3N-6)(3N-6) and solving for the atomic positions that are 
the solution of the system. Large matrices must be inverted as part of this approach. 




The general strategy is to use steepest descents for the first 10-100 steps(500-1000 
steps for proteins or nucleic acids) and then use conjugate gradients or Newton-Raphson to 
complete minimization for convergence(using RMS gradient or/and energy difference as an 
indicator). For most calculations, RMS gradient is set to 0.10 (you can use values greater 
than 0.10 for quick, approximate calculations). 
The calculated minimum represents the potential energy closest to the starting 
structure of a molecule. The energy minimization is often used to generate a structure at a 
stationary point for a subsequent single-point calculation or to remove excessive strain in a 
molecule, preparing it for a molecular dynamic simulation. 
 
7 Types of Calculations 
 Computational chemistry (also called molecular modelling; the two terms mean 
about the same thing) is a set of techniques for investigating chemical problems on a 
computer. Questions commonly investigated computationally are: 
 
7.1 Molecular Geometry: The shapes of molecules – bond lengths, angles and 
dihedrals. 
7.2 Geometry Optimization [49] is a standard computational chemistry calculation 
to find the lowest energy or most relaxed conformation for a molecule. The approach is the 
same for all levels of calculation, involving an iterative “jiggling” process like that described 
for molecular mechanics. 
At each step, the molecular geometry is modified slightly and the energy of the 
molecule is compared with the last cycle. The computer moves the molecule a little, 
calculates the energy, moves it a little more, and keeps going until it finds the lowest energy.  
This is the energy minimum of the molecule and is obtained at the optimized geometry. 
Recall that the energies from molecular mechanics can only be used in a relative sense, while 
those from quantum electronic structure methods can be compared in an absolute sense, like 
heats of formation. 




7.3 Single Point Calculations [49] are often used in combination with a geometry 
optimization to investigate steric hindrance. In this case the method only performs one 
computational cycle to calculate the energy of a particular fixed geometry. In a 
thermodynamically controlled reaction, the energetic difference between two conformations is 
often due to steric hindrance.  If the product molecule optimizes in one conformation, you can 
use single point calculations to determine how much more energy is needed to form the non-
preferred conformation. 
The structure drawing and manipulation part of the software will allow you to move 
only that part of the molecule that changes in the higher energy form, leaving the rest of the 
molecule optimized. 
The single point calculation performed on this modified molecule will give an energy 
that you can directly compare with the optimized energy to find the energy difference 
between the lower and higher energy conformers.  For example, the energetic difference 
between having a constituent in the axial or equitorial position on a cyclohexane ring can be 
determined. 
 
7.4 Transition State Calculations [49] can be thought of as the reverse of geometry 
optimizations. In this case, the method searches for a structure of maximum energy, a 
transient intermediate which cannot be isolated experimentally. For example, this type of 
calculation allows one to examine transition state energies and geometries of intermediates 
involved in carbocation rearrangements. 
The literature contains standard models that should use as the starting point for these 
calculations.  It takes a far amount of effort and experience to properly analyze transition state 
structures and energies. 
 
7.5 Electronic Density and Spin Calculations, Graphical Models and 
Property Maps [49] Allow visualization of electronic properties such as electron densities, 
electrostatic potentials, spin densities and the shapes and signs of molecular orbitals.  




The values for a particular property at each point in the 3-dimensional space around a 
molecule are displayed on the 2-dimensional computer screen as a surface of constant 
numerical value, often called an isosurface which can be rotated in any direction to study it.   
Alternately, numerical variations of a given property (such as electron density) at a 
defined distance from the molecule can be displayed as property maps using color as a key 
yielding what is called a property map. Carrying out surface calculations and viewing their 
graphical representations are major activities in computational chemistry and can provide 
useful insight into the mechanisms of organic reactions. 
7.6 Chemical Reactivity : [50] 
For example, knowing where the electrons are concentrated (nucleophilic sites) and where 
they want to go (electrophilic sites) enables us to predict where various kinds of reagents will 
attack a molecule.  
  
7.7 IR, UV and NMR spectra : [50] these can be calculated, and if the molecule is 
unknown,  someone trying to make it knows what to look for.allow the calculation of infrared 
stretching and bending absorption frequencies and it is a lot of fun to view animations of these 
types of motions in molecules.  
 The vibrational frequency of a two-atom system is proportional to the square root of 
the force constant (the second derivative of the energy with respect to the interatomic 
distance) divided by the reduced mass of the system (which depends on the masses of the two 
atoms). 
 
8.  Scope of application of molecular modeling : 
 Molecular modeling methods are used to investigate the structure, dynamics, surface 
properties and thermodynamics of inorganic, biological and polymeric systems.  
Molecular modeling methods are used in the fields of computational chemistry, drug design, 
computational biology and materials science for studying molecular systems (small and large 
chemical systems). Also are used to predict molecular behaviours specifically interactions 
between molecules. 




Molecular mechanics calculates the energy of a molecule, like the steric energy, the 
energy due to the geometry or conformation of a molecule. 
 
8.1  QSAR Methods : 
8.1.1 Introduction: 
It has been nearly 40 years since the quantitative structure-activity relationship 
(QSAR) paradigm first found its way into the practice of agrochemistry, pharmaceutical 
chemistry, toxicology, and eventually most facets of chemistry [51] 
If we can understand how a molecular structure brings about a particular effect in a 
biological system, we have a key to unlocking the relationship and using that information to 
our advantage, formal development of these relationships on this premise has proved to be 
the foundation for the development of predictive models, if we take a series of chemicals 
and attempt to form a quantitative relationship between the biological effects (i.e. the 
activity) and the chemistry (i.e. the structure) of each of the chemicals, then we are able to 
form a quantitative structure–activity relationship or QSAR. [52] 
QSAR, a quantum chemical technique [53,54] , is known to relate the biological 
activity of compounds with their molecular structure [55] and has been extensively used as 
predicting tool in rational drug design [56-61]. 
Computational evaluation to give predictive QSAR models is an important tool to 
avoid unnecessary experimental assays and find an optimum drug target. [62] 
 
8.1.2  Historical Development of QSAR :                      
More than a century ago, Crum-Brown and Fraser expressed the idea that the 
physiological action of a substance was a function of its chemical composition and 
constitution [63]. 
  A few decades later, in 1893, Richet showed that the cytotoxicities of a diverse set of 
simple organic molecules were inversely related to their corresponding water solubilities 
[64]. 




  At the turn of the 20th century, Meyer and Overton independently suggested that 
the narcotic (depressant) action of a group of organic compounds paralleled their olive 
oil/water partition coefficients [65,66]. 
 In 1939 Ferguson introduced a thermodynamic generalization to the correlation of 
depressant action with the relative saturation of volatile compounds in the vehicle in which 
they were administered [67]. 
In 1962 Hansch and Muir published their brilliant study on the structure-activity 
relationships of plant growth regulators and their dependency on Hammett constants and 
hydrophobicity [68]. 
The Free-Wilson approach addresses structure-activity studies in a congeneric series 
as described in Equation 14 [69]. 
                                         BA = Σ ai xi + u                            (14) 
BA is the biological activity, u is the average contribution of the parent molecule, and ai is 
the contribution of each structural feature; xi denotes the presence Xi= 1 or absence Xi= 0 of 
a particular structural fragment. 
Limitations in this approach led to the more sophisticated Fujita-Ban equation that used the 
logarithm of activity, which brought the activity parameter in line with other free energy-
related terms [70].  
 
Log BA = Σ Gi xi + u                            (15) 
In Equation 15, u is defined as the calculated biological activity value of the unsubstituted 
parent compound of a particular series. I represents the biological activity contribution of 
the substituants, whereas Xi is ascribed with a value of one when the substituent is present 
or zero when it is absent. 
 
 





8.1.3 Tools and techniques of QSAR: 
8.1.3 .1 Biological parameters:  
In QSAR analysis, it is imperative that the biological data be both accurate and 
precise to develop a meaningful model, it must be realized that any resulting QSAR model 
that is developed is only as valid statistically as the data that led to its development, 
biological data are usually expressed on a logarithmic scale because of the linear relationship 
between response and log dose in the midregion of the log dose-response curve, inverse 
logarithms for activity (log 1/C) are used so that higher values are obtained for more 
effective analogs, it is also important to design a set of molecules that will yield a range of 
values in terms of biological activities. Generally, the larger the range (>2 log units) in 
activity, the easier it is to generate a predictive QSAR [71]. 
 
 8. 1.3. 2. Molecular descriptors :   
  These are truly structural descriptors because they are based only on the two-
dimensional representation of a chemical structure [71]. The most widely known descriptors 
are those that were originally proposed by Randic [72]. and extensively developed by Kier 
and Hall [73].   
Molecular descriptors are formal mathematical representations of a molecule, 
obtained by a well-specified algorithm, and applied to a defined molecular representation or 
a well-specified experimental procedure: the molecular descriptor is the final result of a logic 
and mathematical procedure which transforms chemical information encoded within a 
symbolic representation of a molecule into a useful number or the result of some 
standardized experiment [74].   
Molecular descriptors play a fundamental role in developing models for chemistry, 
pharmaceutical sciences, environmental protection policy, toxicology, ecotoxicology, health 
research, and quality control [21].  




Evidence of the interest of the scientific community in molecular descriptors is 
provided by the huge number of descriptors that have been proposed: more than 5000 
descriptors [74]. derived from different theories and approaches are defined and 
computable by using dedicated software of chemical structure. [21] 
Molecular descriptors are numerical indexes encoding some information related to 
the molecular structure, they can be both experimental physico-chemical properties of 
molecules and theoretical indexes calculated by mathematical formulas or computational 
algorithms, they are derived by applying principles from several different theories, such as 
quantum-chemistry, information theory, organic chemistry, graph theory, they are used to 
model several different properties of chemicals in scientific fields such as toxicology, 
analytical chemistry, physical chemistry, medicinal, pharmaceutical, and environmental 
chemistry [21]. 
 
8. 1. 3. 3. Statistical methods : 
Quantitative structure activity relationships (QSAR) in the past 50 years have been 
considered a versatile tool for the activities prediction of drug and drug-like molecules, the 
aim of developing a QSAR model is to construct a relation (using statistical methods) 
between structures and activities. [75] 
In most cases, it is more convenient to consider a linear relationship between 
activity/property and descriptors.[76]  
The most commonly used modeling methods are [76]: 
- Multiple linear regression (MLR),  
- principal component regression (PCR),  
- partial least squares (PLS) regression, 
- artificial neural networks (ANN). 
The most widely used method is the multiple linear regression (MLR) approach originally 
proposed by Bartlett and Youd (1995). [77] 





8. 1. 3. 4. Multi-linear regression : 
Multi-linear regression (MLR) is a statistical method for studying the relationship 
between a dependent variable and two or more independent variables. 
In this method, a dependent variable Y is described in terms of a series of explanatory 
variables X1, . . ., Xn, as given in Eq 16 : 
                 Y= Y0 + a1 X1 + a2 X2 + ··· + an Xn                          (16) 
 
It is assumed that all the explanatory variables are independent of each other [78]. 
 
✓ Description of the method : 
The analysis of multiple linear regression (MLR) is a statistical method that examine 
cause-effect relationships between dependent and independent variables, in MLR, the 
relationship between input variable more than one (x1 ,x2, . . .xn) and a dependent variable 
(y) is examined [79]. 
If it is assumed that the relationship is well represented by a model that is linear in the 
regressed variables, a suitable model may be [76]: 
 
                        y = b0 + b1 x1 + b2 x2 ….+e                            (17) 
In Eq 17, the b’s are unknown constants called regression coefficients and the objective of 
regression analysis is to estimate these constants, the algebraic MLR model is defined in Eq 
17, and in matrix notation.  [76]:  
                              y = X β + ɛ                           (18) 
 
 




The matrix X is referred to as the design matrix : 
    
 
Multiple linear regression (MLR) techniques based on least-squares procedures are 
very often used for estimating the coefficients involved in the model equation [80,81]. 
 
✓  Test of the total significance of the regression : 
 
a. Determination coefficient (R2) : 
The coefficient of determination (R2) is a measure of how well the regression line 
 represents the data on the scatter plot. R2 is a measure of the fit of the regression model 
[66].  
The R2 can be used to determine the linear relationship between the measured and 
estimated values. [79]. R2  ranges from 0 to 1.          
The coefficient of determination R2 is the ratio of the explained sum of squares to the 
total sum of squares.  
 









                   (18) 
 
where: 
TSS is the total sum of squares:             TSS = ∑(𝒀𝒐𝒃𝒔 − ?̅? )
𝟐
                   (19)    
               




ESS ist he explained sum of squares:    ESS = ∑(𝒀𝒄𝒂𝒍 − ?̅? )
𝟐
                    (20) 
    
RSS is the residual sum of squares:      RSS = ∑(𝒀𝒐𝒃𝒔 − 𝒀𝒄𝒂𝒍)
𝟐
                 (21) 
 
b. Correlation coefficient (R) 
The quantity R, called the correlation coefficient, it is a correlation coefficient 
between observed and predicted values of dependant variable Y, where 0 < R < 1 
 
                  R= (ESS/TSS)0.5  = (1-RSS/TSS)0.5                  (22) 
 
 
c. Test Fisher-Snedecor (F)  
F the Fisher test, reflects the ration of the variance explained by the model and 
variance due to error in the model, high values of F-test indicate the significance of the 
equation. [82]               
                              F = [ESS/ (k)] / [RSS / (n-k-1)]                (23) 
Where n, and (k-1) are degrees of freedom associated to ESS and RSS respectively.   
 
d. Standard deviation (s) 
S is called the standard deviation 
                            𝒔 = √
𝑹𝑺𝑺
𝒏−𝒌−𝟏
               (24) 
    Where k is the number of independent variables. 
 
 





e. Prediction coefficient (Q2) 
it measures the predictive capacity of a model       𝑸𝟐 =  𝟏 −
𝑷𝑹𝑬𝑺𝑺
𝑺𝑺𝒀
                 (25) 
 
8.1.4 Models Validations : 
 
The best multiple linear regression model is one that has high R and F-values, low 
standard error, the least number of variables and high prediction ability [83]. 
To test the validity of the predictive power of model we use some techniques: 
Cross-validation LOO (leave-one-out) is a model validation technique, for assessing how the 
results of a statistical analysis will generalize to an independent data set, in which we use 
these  statistical parameters: 
PRESS (predicted residual sum of squares)   PRESS = ∑(𝐘𝐨𝐛𝐬 − 𝐘𝐜𝐚𝐥)
𝟐
        (26) 
TSS (total sum of squares)                          TSS = ∑(𝐘𝐨𝐛𝐬 − 𝐘 )
𝟐
                (27) 
R2adj (adjusted R-squared)               R2adj = (𝟏 − 𝐫𝟐) (
𝐧−𝟏
𝐧−𝐩−𝟏
)                         (28) 
 
R2CV (cross-validated correlation coefficient)    R2CV = 1- 
𝐏𝐑𝐄𝐒𝐒
𝐓𝐒𝐒
                     (29)   
SPRESS (standard validation of the prediction errors)     SPRESS = √
𝐏𝐑𝐄𝐒𝐒
𝐧
          (30) 
 
PE (Prediction error)          PE = 𝟎. 𝟔𝟕𝟒𝟓 (𝟏 − 𝐫𝟐)/√𝐧                               (31) 
 





The PRESS (predicted residual sum of squares) statistic appears to be the most 
important parameter accounting for a good estimate of the real predictive error of the 
models. Its small value indicates that the model predicts better than chance and can be 
considered statistically significant [76]. 
 
9. Programs and materials used: 
 This work was carried out within team of Computational and pharmaceutical 
chemistry of the laboratory of molecular chemistry and environment (LMCE) at the 
university of Biskra. 
 The first calculations were optimized by using a software HyperChem 8.03 [84] 
The geometry of macrolides and its derivatives initially were entirely optimized by molecular 
mechanics, with the force field MM + (rms = 0.001 Kcal / A). Further geometries were fully 
re-optimized by using PM3 method.  
  Then a parallel study was made by using the Gaussian software 09 [85]. One based 
on ab initio of Hartree-Fock (HF) type HF/6-31++G (d,p), and the density functional theory 
DFT with functional calculus B3LYP, by using the following base : 6-31++G (d,p). 
DFT with B3LYP/6-31G, this theory was used to calculate a number of electronic 
descriptors: dipole moment (DM), energy of frontier orbital’s, EHOMO and ELUMO. 
Multiple linear regression analysis of molecular descriptors was carried out using the 
stepwise strategy in SPSS version 19 for Windows [86]. 
All calculations are carried out in a Station in a PC  (SAMSUNG Intel insideTM Micro-
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  Molecular modeling can be defined as the generation, manipulation, calculation, and 
prediction of realistic molecular structures and associated physicochemical as well as 
biochemical properties by the use of a computer. It is primarily a mean of communication 
between scientist and computer, the imperative interface between human-comprehensive 
symbolism, and the mathematical description of the molecule.[1] 
  The types of predictions possible for molecules and reactions include [2]: 
• Heats of formation 
• Bond and reaction energies 
• Molecular energies and structures (thermochemical stability) 
• Energies and structures of transition states (activation energies) 
• Reaction pathways, kinetics and mechanisms 
• Charge distribution in molecules (reactive sites) 
• Substituent effects • Electron affinities and Ionization potentials 
• Vibrational frequencies (IR and Raman spectra) 
• Electronic transitions (UV/Visible spectra) 
• Magnetic shielding effects (NMR spectra) 
  Prediction of these properties has many applications in energetic materials research, 
including studies of synthesis pathways, reaction products and initiation mechanisms. 
  Quantum chemistry methods play an important role in obtaining molecular 
geometries and predicting various properties [3]. To obtain highly accurate geometries and 
physical properties for molecules that are built from electronegative elements, expensive ab 
initio/HF electron correlation methods are required [4-6]. Density functional theory methods 
offer an alternative use of inexpensive computational methods which could handle relatively 
large molecules [7-16]. 
 
2. Mulliken population analysis (MPA) 
 This population analysis is the oldest and one of the most widely used. MPA divides 
bond orbital populations equally between the two atoms of a bond.  
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This approach is very simplified and does not take into consideration that one of bonded 
atoms can attract electrons markedly more than the second one. On the other hand, the 
simplicity of MPA is sometimes an advantage because the method can be easily used.[17] 
 
 
3. Electrostatic Potential Surface (MESP) 
 The molecular electrostatic potential is the potential energy of a proton at a particular 
location near a molecule. 
• Negative electrostatic potential corresponds to an attraction of the proton by the 
concentrated electron density in the molecules (from lone pairs, pi-bonds, etc.) 
(colored in shades of red). 
• Positive electrostatic potential corresponds to repulsion of the proton by the 
atomic nuclei in regions where low electron density exists and the nuclear charge 
is incompletely shielded(colored in shades of blue). 
The more red / blue differences, the more polar the molecule. If the surface is largely white 
or lighter color shades, the molecule is mostly non-polar. The MESP may be employed to 
distinguish regions on the surface which are electron rich (subject to electrophilic attack) 
from those which are electron poor (subject to nucleophilic attack) and has been found to be 
a very convenient tool in exploration of correlation between molecular structure and the 
physiochemical property relationship of molecules including bio molecules and drugs [18-23]. 
The electrostatic potential V(r) at any point in space around a molecule by charge distribution 
is given by: 
 
 
Where the summation runs over all the nuclei A in the molecule and polarization and 
reorganization effects are neglected. ZA is the charge of the nucleus A, located at RA and ρ(r') 
is the electron density function of the molecule. 
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4. Dipole Moment 
An electric dipole consists of a pair of charges of equal magnitude and opposite signs 
(+q and –q), separate by a distance (r). The dipole moment of an electric dipole is a vector 
directed from the negative to the positive charge. The magnitude of the dipole moment is 
measured in Coulomb meters (Cm) or in debye (D), where 1D = 3.338*10-30 Cm. [24] 
If the positive and negative charges in a molecule do not overlap, the molecule 
possesses a permanent dipole moment (µ) (polar molecule). Molecular dipole moment is 
usually calculated using the following formula: 
 
Where r is the radius-vector of an atom i from the origin of the coordinate system (Centre of 
charge or Centre of mass) 
• is the partial charge of atom i 
• The summation is over all atoms in the molecule. 
 
5. Heat of Formation (∆Hf) 
The heat of Formation is known as the change in enthalpy accompanying the formation of 
one mole of a compound from its elements in their natural and stable states, under standard 
conditions of one atmosphere at a given temperature [25]. 
 The quantum chemical and energy descriptors are useful parameters for describing QSAR 
of a chemical system. A more useful quantity the heat of formation of the compound from its 
elements in their standard state. This is equal to the energy required to ionize the valence 
electrons of the atoms involved. The heat of formation is defined as: 
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Where Eelec  is the electronic energy, Enuc  is the nuclear-nuclear repulsion energy, Eiso  is the 
energy required to strip all the valence electrons of all the atoms in the system and Eatom is 
the total heat of atomization of all the atoms in the system. 
 
6. Energies of the Frontier Molecular Orbitals HOMO and 
LUMO 
The energies of the frontier orbitals HOMO (highest occupied molecular orbital) and 
LUMO (lowest unoccupied molecular orbital) are commonly used descriptors in QSAR 
analysis. They reflect the reactivity of a molecule. A higher HOMO energy suggests higher 
affinity of a molecule to react as a nucleophile, a lower LUMO energy suggests stronger 
electrophilic nature of a molecule. 
Additionally, electrophilic and nucleophilic attack will most likely occur at atoms where 
the coefficients of the corresponding atomic orbitals in HOMO and LUMO, respectively, are 
large. [24] 
 
7. Substituent Effects on the Electronic Structure 
The measure of some important electronic properties such as ionization energy, electron 
affinity, etc., through the introduction of electron donating (ED) or electron withdrawing (EW) 
substitutions follows a long established method in bio-chemical and molecular electronics 
engineering. [26-30] 
ED substituents (donor Substituents) can increase the energies of highest occupied 
molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) relative to that of 
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Figure 3.1. Influence of energy level of the donor group (ED) 
 
EW substituents (Acceptor Substituents) can decrease the energies of lowest unoccupied 
molecular orbital (LUMO) and highest occupied molecular orbital (HOMO) relative to that of 
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8. Material and methods 
 
 
Figure 3.3  α, β unsaturated macrolactone. 
 
Initial calculations were optimized using HyperChem 8.03 software [31]. The  
geometries  of  macrolides  and  its  derivatives were first fully optimized by molecular 
mechanics, with MM+ force-field  (rms  =  0.001  Kcal/Å).  Further, geometries were fully re-
optimized by using PM3 method [32]. In the next step geometries were fully re-optimized by 
using Ab initio/HF (STO-3G). The calculated results have been reported in the present work.  
 
9. Results and discussion 
  
9.1. Conformational Analysis of 14-Membered α, β -Unsaturated Macrolides 
The most stable structures can be characterized by three structural characters: the 
diene group, the α, β –unsaturated ester group, and the two saturated chains (Figure 3.3) 
[33]. Thus, we have obtained eight types of conformations which are present in the majority 
of cases in an 5 kcal/mol energy range above the global minimum. The conformation types 
are classed from 1 to 8 [34]. 
 For types (2, 4, 6, 8), the two planes of two conformational sites, diene and α, β -
unsaturated ester group are pseudo parallels; but for types (1, 3, 5, 7), the two planes of the 
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             T1          T3             T5                T7  
    
            T2              T4                T6               T8 
 
Figure 3.4.  Main conformational types of macrolides. 
 
In 2 kcal/mol difference, the macrocycle 14s is characterized by the first conformer 
type 6, which is the most favored with 23.7% rate followed by a type 4 with 16.6%, this is 
done using the Boltzmann statistical method. 
Then, the macrocycle 14d (Figure 3.1) is presented preferably in the type T3 with 
24.9%. The percentages of other conformers are listed in Table 3.1. 
 
Table 3.1. Energetic difference and Boltzmann population for different macrolide 
types. 
Macrolides 14 symmetric (n1 = n2 = 3) 14 dissymmetric (n1 =2, n2 = 4) 
to 2 kcal/mol Type ΔE % Type ΔE % 
6 0.00 23.7 3 0.00 24.9 
4 1.58 16.6    
Sup to 2 Kcal/mol 3 2.49 13.3 6 2.03 15.2 
2 3.12 11.4 4 2.61 13.2 
7 3.35 10.8 7 3.35 11.1 
1 4.45 08.2 1 3.49 10.7 
5 4.48 08.2 5 3.64 10.3 
8 4.72 07.7 8 4.52 08.3 
   2 5.78 06.2 
Note: ΔE: Energetic difference to the absolute minimum, %: Boltzmann population. 
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9.2. Geometric and Electronic Structure of Basic Structure of 
Symmetric 14-membered Macrolide Type 6 (T6) 
 
 
     Figure 3.5. The privileged Conformations of the macrocycle 14s (T6) 
 
 The efficiency of PM3 method may be scrutinized by comparison with the results 
obtained by more elaborate calculation such as ab initio/HF(STO- 3G).  
 
Present results concerning from these results a good correlation can be seen between the ab 
initio, and PM3 for bond lengths, also the charge densities calculated by these methods are 
approximately similar, Table 3.2. 
 The geometric study allow to see that ester α, β –unsaturated system for the 14S 
macrolide type 6 (Figure 3.5) has an S-CIS form with a dihedral angle Φ1 = O15-C1-C2-C3 = 
2.861° using molecular mechanic calculation; 046.395°  using PM3 method and 018.671°  via 
ab-initio/HF method. Also it allows to see that the diene system, it has an S-TRANS form, with 
a dihedral angle of Φ2 = C7-C8-C9-C10 = 175.583° using MM calculation, 175.195°  via PM3 
method and 163.269 °  using ab-initio method. 
Finally, we conclude that ester α, β -unsaturated and diene systems for the two macrocycles 
are perpendicular on medium plans of cycles. 
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Table 3.2 Bond lengths (in Å) and valence angles (in degree) of the macrocycle 14s 
(T6) as computed at different levels of theory. See Figure 3.5 for the numbering of the atoms. 
ab initio 
/HF 
PM3 MM+ Distance ab initio /HF PM3 MM+ Distance 
1.3176 1.3387 1.3449 C7-C8 1.2196 1.2168 1.2095 C1-O15 
1.4871 1.4516 1.3434 C8-C9 1.3958 1.3709 1.3501 C1-O14 
1.3168 1.3372 1.3437 C9-C10 1.5119 1.4809 1.3594 C1-C2 
1.5293 1.4891 1.5101 C10-C11 1.3165 1.3349 1.3447 C2-C3 
1.5483 1.5237 1.5391 C11-C12 1.5224 1.4854 1.5094 C3-C4 
1.5499 1.5294 1.5387 C12-C13 1.5492 1.5243 1.5537 C4-C5 
1.4383 1.4198 1.4085 C13-O14 1.5517 1.5248 1.5540 C5-C6 
 1.3165 1.4869 1.5120 C6-C7 
ab initio 
/HF 
PM3 MM+ Angle ab initio /HF PM3 MM+ Angle 
125.004 123.025 124.023 C9-C10-C11 125.218 124.782 127.451 C1-C2-C3 
114.463 114.488 115.791 C10-C11-C12 126.816 126.343 129.921 C2-C3-C4 
114.004 113.574 114.822 C11-C12-C13 113.820 113.109 111.84 C3-C4-C5 
114.031 113.022 113.540 C12-C13-O14 114.614 113.157 113.224 C4-C5-C6 
113.292 119.674 119.859 C13-O14 -C1 113.537 112.899 111.908 C5-C6-C7 
122.775 119.571 119.703 O14-C1-O15 127.794 124.513 128.120 C6-C7-C8 
127.588 128.808 121.920 C2-C1-O15 127.077 123.292 126.105 C7-C8-C9 
 123.033 122.989 123.275 C8-C9-C10 
ab initio 
/HF 
PM3 MM+ Torsion 
angle 
ab initio /HF PM3 MM+ Torsion 
angle 
054.751 032.791 046.313 C9-C10-C11-C12 002.594 002.809 002.052 C1-C2-C3-C4 
068168 084.717 068.295 C10-C11-C12-C13 123.816 113.966 116.788 C2-C3-C4-C5 
056.740 076.327 057.525 C11-C12-C13-O14 70.818 87.496 063.701 C3-C4-C5-C6 
075.409 080.478 067.379 C12-C13-O14-C1 076.652 092.997 075.170 C4-C5-C6-C7 
176.267 168.061 170.332 C13-O14 –C1-C2 120.059 120.741 120.784 C5-C6-C7-C8 
003.566 013.693 007.330 C13-O14-C1-O15 001.359 003.591 001.039 C6-C7-C8-C9 
018.671 046.395 002.861 O15-C1-C2-C3 163.269 175.195 175.583 C7-C8-C9-C10 
 178.995 177.621 178.497 C8-C9-C10-C11 
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 The Table 3.3 shows that the atoms C2, C3, C4, C5, C6, C7, C8, C9, C10, C11, C12, O14 and O15 
have negative Mulliken charges which leads to electrophilic substitution, whereas the atom C1 
and C13 have positive Mulliken charge which lead to preferential site nucleophilic attack. 
 
 ab initio/HF PM3 Atoms 
0.310 0.418 1C 
-0.097 -0.194 2C 
-0.027 -0.046 3C 
-0.116 -0.092 4C 
-0.093 -0.085 5C 
-0.108 -0.077 6C 
-0.060 -0.143 7C 
-0.068 -0.101 8C 
-0.078 -0.141 9C 
-0.050 -0.119 10C 
-0.106 -0.061 11C 
-0.106 -0.138 12C 
0.012 0.074 13C 
-0.258 -0.264 14O 
-0.275 -0.385 15O 
 
Table 3.3.  Mulliken charges of basic structure of macrolide T6. 
 
 
9.3. The molecular electrostatic potential MESP of basic structure (T6)  
The molecular electrostatic potential surface MESP which is a plot of electrostatic 
potential mapped onto the iso-electron density surface simultaneously displays molecular 
shape, size and electrostatic potential values and has been plotted for both the molecules.  
Molecular electrostatic potential (MESP) mapping is very useful in the investigation of 
the molecular structure with its physiochemical property relationships [35-40].  
In this study, the electrostatic potentials at the surface are presented by different 




CHAPTER 3: Geometric, Electronic Structure and Substituent effects of  









Figure 3.6.  3D MESP contour map for 14 macrolide molecule (Gaussian 09). 
 
 Red color parts represent the regions of negative electrostatic potential while yellow 
ones represent regions of positive electrostatic potential. Green color parts represent also 
regions of zero potential. A portion of the molecule that has a negative electrostatic 
potential is susceptible to electrophilic attack while the positive ones are related to 
nucleophilic reactivity. 
9.4.  Substituent effects on the electronic structure in symmetric 14-
membered macrolides 
 Ab initio/HF method with (STO-3G) basis set was used to investigate the effects of a 
variety of substituents (-CH3 and -F) on the electronic and structural properties of 
macrolide. 
 In Table 3.4 and Table 3.5, HOMO and LUMO energies, energy gaps ΔE, heat of 
formation and dipole moments are reported for macrolide and its derivatives. The chemical 
structures of the studied macrolide and its derivatives are shown in Figure 3.7. 
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2. R1=R7=F, R2=R3=R4=R5=R6=R8=R9=R10=R11=R12=H 
3. R2=R8= F, R1=R3=R4=R5=R6=R7=R9=R10=R11=R12=H 
4. R3=R9= F , R1=R2=R4=R5=R6=R7=R8=R10=R11=R12=H 
5. R4=R10= F, R1=R2=R3=R5=R6=R7=R8=R9=R11=R12=H 
6. R5=R11= F, R1=R2=R3=R4=R6=R7=R8=R9=R10=R12=H 
7. R6=R12= F, R1=R2=R3=R4=R5=R7=R8=R9=R10=R11=H 
 
 
























1 macrolides -54.5684 -5.6027 -1.0296 4.5731 1.101 
2 2,8-dimethyl macrolide -70.7862 -5.5480 -0.9132 4.6348 1.313 
3 3,9-dimethyl macrolide -67.2676 -5.5456 -0.8666 4.6790 0.997 
4 4,10-dimethyl macrolide -67.5177 -5.4356 -1.0215 4.4141 1.252 
5 5,11-dimethyl macrolide -64.6269 -5.5899 -1.0468 4.5431 1.124 
6 6,12-dimethyl macrolide -65.1767 -5.6035 -0.9972 4.6063 1.085 
7 7,13-dimethyl macrolide -67.9773 -5.4286 -0.9698 4.4588 1.135 
Note: Heat of formation by PM3 by HyperChem 8.06. HOMO, LUMO, ΔE and μ by Ab initio/HF (STO-3G). 
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1 macrolides -54.5684 -5.6027 -1.0296 4.5731 1.101 
2 2,8-difluorine macrolide -139.1277 -5.7815 -1.2601 4.5214 1.486 
3 3,9- difluorine macrolide -139.9724 -5.8465 -1.0432 4.8033 1.214 
4 4,10- difluorine macrolide -138.3979 -5.7306 -1.4843 4.2463 2.218 
5 5,11- difluorine macrolide -137.8738 -6.0830 -1.3782 4.7048 1.513 
6 6,12- difluorine macrolide -136.5750 -6.1690 -1.4174 4.7516 3.000 
7 7,13- difluorine macrolide -148.3032 -5.6715 -1.3692 4.3023 0.904 
 
Note: Heat of formation by PM3 by HyperChem 8.06. HOMO, LUMO, ΔE and μ by DFT/B3LYP. 
Table 3.5 Energies of macrolide and di-fluorine substitute macrolides (Series 2). 
 
 
The heat of formation is decreased at each addition of di-methyl groups. Compound 2 
(2, 8-dimethyl macrolide) has the smallest value of the heat of formation. This compound (2) 
is more stable compared to other derivatives.  
 As has been seen by calculating the effect of a substituent donor increase the energy 
of the HOMO and that of the LUMO, while we see by calculating the effect of a substituent 
acceptor decrease the energy of the HOMO and that of the LUMO, Results in a stabilization of 
the HOMO and LUMO. 
 In the substituted di-methyl group category, the 4,10-dimethylmacrolide (compound 
4) has smaller HOMO-LUMO energy gap (4.4141) Table 4 depicts the chemical reactivity of 
the compound; higher is the HOMO-LUMO energy gap, lesser is the flow of electrons to the 
higher energy state, making the molecule hard and less reactive. On the other hand in smaller 
HOMO-LUMO gap, there is easy flow of electrons to the higher energy state making it softer 
and more reactive (HSAB principle: hard and soft acids and bases).  
  Hard bases have highest-occupied molecular orbitals (HOMO) of low energy, 
and hard acids have lowest-unoccupied molecular orbitals (LUMO) of high energy [45]. 
The heat of formation is decreased at each addition of di-fluorine groups. Compound 
7 (7,13- difluorine macrolide) has the smallest value of the heat of formation. This compound 
(7) is more stable compared to other derivatives.  
As has been seen by calculating the effect of a substituent donor increase the energy of the 
HOMO and that of the LUMO.  
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 In the substituted di- fluorine group category, the 4,10-fluorine macrolide (compound 
4) has smaller HOMO-LUMO energy gap (4.2463) Table 5 depicts the chemical reactivity of 
the compound; higher is the HOMO-LUMO energy gap, lesser is the flow of electrons to the 

























Figure 3.8.  Schematic drawings of the HOMO and LUMO of compound 1(Gaussian 09). 
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The contour plots of the π-like frontier orbital's for the ground state of compound B1 are 
shown in (Figure 3.8), The  positive phase  is  red  and  the  negative  one  is  green. from the 
plots, one can find that the HOMO mainly concentrates on the diene group, whereas, the 
LUMO distributes over the α, β –unsaturated ester group with some delocalization along the 
diene group. These further demonstrate that there exists the delocalization of the 
conjugated π-electron system in the molecule of compound 1. 
 
10. Conclusion 
 The present work studied the molecular proprieties of 14-membered 
macrolides. The PM3, and ab initio method can be used quite satisfactorily in 
predicting the chemical reactivity of the molecules and the effect of substitution of 
either donor or acceptor electron. 
 The 4, 10-di-methyl macrolide is predicted to be the most reactive with least 
HOMO-LUMO energy gap (4.4141) of all macrolide systems substituted by di-methyl, 
and in the substituted di-fluorine group category, the 4,10-fluorinemacrolide has 
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The idea that the physiological effects of a substance depend on its chemical 
composition and structure was first formulated more than a hundred years ago [1] . Today 
this approach is widely used in biochemical, pharmaceutical and other fields of science 
where predicting properties of chemical compounds is necessary. The popularity of this 
approach is based on the now obvious statement that the biological or physicochemical 
activity of the compound is a function of its structure, represented by a set of directly 
measurable or computable parameters [2-6]. Heterocyclic compounds hold a special place 
among the major pharmaceutical natural products and synthetic drugs having different 
biological activities [7]. 
 The useful properties of macrolides range from perfumery to biological and 
medecinal activity . The new finding in the field of antitumour active and other antibiotic 
macrolides, together with pheromones and plant growth regulators with macrolactone 
framework, are an inspiration to chemists to study macrolides. The term “macrolide” is used 
to describe drugs with a macrocyclic lactone ring of 12 or more elements. [8] The 14-, 15-, 
and 16-membered macrolides are a widely used family of antibiotics. They have excellent 
tissue penetration and antimicrobial activity, mainly against Gram-positive cocci and atypical 
pathogens. 
  Macrolide concentrations are at least 10-fold higher in the epithelial lung fluid than 
in serum. Erythromycin A, a 14-membered macrolide, was isolated more than 50  
years ago from cultures of Streptomyces and was the first macrolide introduced into clinical 
practice. [8-10]  
 However, increasing macrolide resistance among respiratory tract pathogensh as led 
to a search for new agents that are more effective against macrolide-lincosamide-
streptogramin group B (MLSB)-resistant strains, and have low potential to select for or 
induce resistance and cross-resistance. The ketolides of which telithromycin (HMR 3647) is 
the first to undrgo clinical development, represent a new family of antmicrobials that are 
derived chemically from the macrolides and have been developed for use against respiratory 
pathogens.[11] 
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A successful drug that passes the hurdles of clinical trials to gain approval and a 
strong market position must exhibit a delicate balance of biological and physicochemical 
properties[12,13]. 
Quantum chemistry methods play an important role in obtaining molecular geometries and 
predicting various properties.[14] To obtain highly accurate geometries and physical 
properties for molecules that are built from electronegative elements, expensive ab 
initio/HF correlation methods are required.[15–17] Density functional theory methods offer 
an alternative use of inexpensive computational methods which could handle relatively large 
molecules.[13], [18–25] 
Quantitative and qualitative Structure-Activity Relationships (QSAR) are attempts to 
correlate molecular structure, or properties derived from molecular structure [5], [20], [25] 
with a particular kind of chemical or biochemical activity. 
The kind of activity is a function of the interest of the user: QSAR is widely used in 
pharmaceutical, environmental, and agricultural chemistry in the search for particular 
properties. The molecular properties used in the correlations relate as directly as possible to 
the key physical or chemical processes taking place in the target activity [26]. 
QSAR has done much to enhance our understanding of fundamental processes and 
phenomena in medicinal chemistry and drug design[27–31]. 
The ability of a drug to penetrate various biological membranes, tissues and barriers 
is a primary factor in controlling the interaction of drugs with biological systems. 
In quantitative structure activity relationship models (QSAR) in which 
physicochemical parameters of drugs are correlated with biological activities, lipophilicity 
(partition Coefficient) has a major role. Other important parameters are polarizability, 
electronic and steric parameters, molecular weight, geometry, etc. 
In this work, we have investigated the geometry, electronic structure and substituent 
effect for 14-membered macrolides derivatives. Finally, we have studied some of QSAR 
proprieties and drug likeness proprieties of a series of 14-membered macrolides and 
ketolides derivatives reported by K. falzari and al [32] and J. Zhu. Zhaohai and al [33]. 
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2. Structure-Property Relationships (SPR) Properties 
 
2.1. Molecular Volume And Surface Area  
Molecular volumes are often calculated by a numerical integration grid technique [34] 
that I can illustrate by considering the trivial problem of finding the volume of an atom 
whose van der Waals radius is R (the volume is of course 
4
3
𝜋𝑅3 )  
Figure 4.1 shows a two-dimensional representation of the atom whose van der Waals 
radius is R, surrounded by a three-dimensional grid of equally spaced points. 
 
Figure 4.1: Grid around atom 
The grid has its centre at the atom centre, and the edges of the grid correspond to the 
van der Waals radius. For each grid point in turn we calculate its distance from the centre 
and determine whether the grid point lies inside or outside the atom. If n is the total number 
of grid points and na the number that lie within the atom whose volume is V, then we have 
 
For a polyatomic, we have to give special consideration to grid points that lie in the 
overlap region. Figure 4.2 shows two atoms, A and B, with radii RA and RB. The overlap 
region is labelled X. 
 
Figure 4.2. Atoms A, B and overlap region X. 
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For atom A, we know that the volume is 
4
3
𝜋𝑅3 . We now surround atom B with a grid, as 
described above, and test each grid point in turn. If the grid point lies within sphere B, then 
we test to see if it lies in region X and so has already been counted as part of the volume of 
atom A. The algorithm proceeds until all atoms have been considered in turn. The molecular 
volume is found by adding all atomic contributions. There are similar methods for the 
estimation of molecular surface area. 
 
2.2. Molecular Refractivity (MR) 
The molar refractivity is a steric parameter that is dependent on the spatial array of the 
aromatic ring in the synthesized compounds. The spatial arrangement also is necessary to 
study the interaction of the ligand with the receptor [35].  
This parameter is a measure of the volume occupied by an atom or group of atoms. The 
molar refractivity is a constitutive-additive property that is calculated by LorenzLorentz 
formula: 
 
where n is the refraction index, Mw is the molecular weight, and ρ is the density. The ( 
n2− 1)/(n2 + 2) term provides a correction factor by defining how easily the substituent can 
be poralized, whereas the Mw/ρ term defines a volume. Molar refractivity is related to the 
lipophilicity, volume, and steric of the molecules. Moreover, it has been correlated with the 
London dispersive force that acts in the drug-receptor interaction. 
 
2.3. Molecular Polarizability (Pol)  
Molecular Polarizability of a molecule characterizes the capability of its electronic system 
to be distorted by the external field, and it plays an important role in modeling many 
molecular properties and biological activities [36].  
It is widely used to describe the inductive and dispersive interaction of a molecule or 
molecular system. In addition, polarizability values have been shown to be related to 
hydrophobicity and thus to other biological activities. It is one of the descriptors that are 
extensively used in QSAR study.  
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Highly polarizable molecules can be expected to have strong attractions with other 
molecules. The molecular polarizabity (α) is also related to molecular refractivity (MR) by the 
Lorentz-Lorenz equation (3) where N0 is the Avogadro constant. 
 
 
2.4. Molecular Weight (MW)  
Molecular weight descriptor has been used as a descriptor in systems such as transport 
studies where diffusion is the mode of operation. It is an important variable in QSAR studies 
pertaining to cross resistance of various drugs in multi-drug resistant cell lines [37]. 
Molecular weight is correlated with the size of the molecule [38]. 
 High molecular weight compounds are likely to show high toxicity as promiscuity of 
compounds is also likely to increase [39]. Additionally, the systemic clearance of a compound 
is inversely proportional to the molecular weight [40]. 
 
2.5. Hydration Energy (HE)  
Hydration energy is very important in the selectivity filter of ion channels where the drug 
is almost entirely strip from the hydration water [41]. Indeed, in the biological environments 
the polar molecules are surrounded by water molecules. They are established hydrogen 
bonds between a water molecule and these molecules. The donor sites of the proton 
interact with the oxygen atom of water and the acceptor sites of the proton interact with 
the hydrogen atom. The first corresponds to the complex with the strongest hydrogen bond. 
These hydrated molecules are dehydrated at least partially before and at the time of their 
interaction. These interactions of weak energy, which we observe in particular between 
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2.6. Partition Coefficient (Log P) 
 One of the most important physicochemical properties much interest in QSAR studies is 
lipophilicity (or hydrophobicity). Because it directly relates to solubility in aqueous phase, to 
membrane permeation (an important factor contributing to the toxicity of chemicals), and to 
its contribution to ligand binding at the receptor site. 
 The ability of a molecule to cross the biological membranes (permeability) is a very 
important bio-pharmaceutic parameter that governs the absorption, distribution, 
metabolism and excretion (pharmacokinetics) of a drug. Enroute to its bio-phase, the drug 
has to partition between the lipid bio-membranes and the aqueous biological fluids. 
Although constituents vary from one membrane to the other, major constituents of bio-
membranes are phospholipids, cholesterol, sphingolipids, and glycolipids (Figure 4.3). 
 
 
Figure 4.3. Polarity of different cellular milieus. 
 
All of these lipids are amphipathic in nature. Therefore, to successfully cross the various 
bio-membranes and to reach its site of action, any drug molecule should have a balance 
between hydrophilic and lipophilic properties. 
The partition coefficient P, defined as the ratio of molar concentration of a chemical 
dissolved at equilibrium in octanol phase Coct to its molar concentration in aqueous phase Caq 
[43-45], (Figure 4.4), and is given by the equation: 
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Figure 4.4. Schematic depictions of the partition of species between octanol and water. 
 
Which [A]O and [A]W are the concentrations of the compound A in organic and aqueous 
phases, respectively. 
The best choice out of various non-polar and slightly polar solvents available is noctanol 
[46] because, it mimics the biological membranes in several aspects:  
• n-octanol has a saturated alkyl chain,  
• it has a hydroxyl group that can act as both hydrogen bond donor as well as acceptor, it 
dissolves water to the extent of 1.7 M,  
• and its solubility parameter (δoctanol=10) is close to that of biological membranes, for 
example skin (δskin=10).  
This combination of lipophilic chains, hydrophilic groups, ability to take up water 
molecules and similar solubility parameter gives n-octanol properties very close to those of 
natural membranes. 
LogP values between 0 and 3 constitutes an optimal window for passive drug absorption. 
A logP value below 0 means that the compound is hydrophilic, and hence it will have a good 
solubility but it may have poor permeability. Whereas, a logP value far higher than 3 means 
that the compound is highly lipophilic, hence, tends to favour absorption, and renders the 
compounds more susceptible to metabolism and / or biliary clearance [47, 48]. The influence 
of lipophilicity on the metabolic clearance of drugs is attributed mainly to the increased 
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2.7. Number of Hydrogen Bond Donors and Bond Acceptors 
Hydrogen bonding is now seen as an important property related to membrane 
permeation. Various scales have been developed [50]. Some of these scales describe total 
hydrogen bonding capability of a compound, while others discriminate between donors and 
acceptors [51]. 
  Hydrogen bonds increase solubility in water and must be broken in order for the 
compound to permeate into and through the lipid bilayer membrane. Thus, an increasing 
number of hydrogen bonds reduces partitioning from the aqueous phase into the lipid 
bilayer membrane for permeation by passive diffusion [38]. Thus, the number of hydrogen 
bond donors and acceptors should be limited in order to minimize the stability of compound 
in aqueous media. 
 
2.8. Druglikeness 
The term drug-like captures the concept that certain properties of compounds are 
most advantageous in their becoming successful drug products. The term became commonly 
used following the pivotal work of Lipinski and his colleagues at Pfizer [52]. Their work 
examined the structural properties that affect the physicochemical properties of solubility 
and permeability and their effect on drug absorption. The term drug-like property has 
expanded and has been linked to all properties that affect ADME/Tox. Although medicinal 
chemists and pharmaceutical scientists had used structural properties in various ways for 
many years, rules became more prominent and defined in the field with the report by 
Lipinski et al [52] of the “rule of 5,” or what has become known as the “Lipinski rules.” These 
rules are a set of property values that were derived from classifying key physicochemical 
properties of drug-like compounds. The rule of five is based on four properties of molecules; 
namely, molecular weight (MW), logP, number of hydrogen-bond donors (HBD) taken as 
equivalent to the number of –OH and –NH groups, and the number of hydrogen-bond 
acceptors (HBA) taken as equivalent to the number of oxygen and nitrogen atoms.  
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A ‘flag’ is set if a molecule’s MW is greater than 500, its logP is greater than 5, the 
number of its HBDs exceeds 5 and the number of its HBAs exceeds 10.  
Because the values of the decision points for all of the property values are multiples 
of five, the above set of rules has been called the ‘Rule of Five’[52]. 
 
2.9. Lipinski Rules 
  Although medicinal chemists and pharmaceutical scientists had used structural 
properties in various ways for many years, rules became more prominent and defined in the 
field with the report by Lipinski et al. [53] of the “rule of 5,” or what has become known as 
the “Lipinski rules.” These rules are a set of property values that were derived from 
classifying the key physicochemical properties of drug-like compounds. The rules were used 
at Pfizer for a few years prior to their publication and since then have become widely used. 
The impact of these rules in the field has been very high. This acceptance can be attributed 
to many factors:  
• The rules are easy, fast, and have no cost to use.   
• The “5” mnemonic makes the rules easy to remember.  
•  The rules are intuitively evident to medicinal chemists.  
• The rules are a widely used standard benchmark.  
•  The rules are based on solid research, documentation, and rationale.  
• The rules work effectively.   
The rule states that the compounds are more likely to be orally bioavailable if they obey the 
following criteria :  
✓ hydrogen bond donors ≤5 (expressed as the sum of all OHs and NHs)  
✓ MW ≤ 500  
✓  logP ≤ 5  
✓  hydrogen bond acceptors ≤10 (expressed as the sum of all Ns and Os). 
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Molecules that violate more than one of these rules may have problems with bioavailability.  
Therefore, this rule establishes some structural parameters relevant to the theoretical 
prediction of the oral bioavailability profile, and is widely used in designing new drugs. 
However, classes of compounds that are substrates for biological transporters such as 
antibiotics, antifungals, vitamins, and cardiac glycosides, are exceptions to the rule [53]. 
 
3. Results and Discussion 
3.1 Study of Structure - activity Relationships for 14-membered Macrolides 
We have studied seven physical and chemical proprieties of a series of fifty Macrolides 
derivatives using HyperChem 8.03 software. For example , in Figure 5 shows the favored 
conformation in 3D of the Clarithromycine. We will continue this work in the future by a 
quantitative calculation. 
 
Figure 4.5. 3D Conformation of Clarithromycine (HyperChem 8.03). 
QSAR proprieties are van der Waals surface molecular volume (V), octanol-water partition 
coefficient (log P), polarizability (pol), Refractivity (Ref), hydration energy (EH), solvent-
accessible surface (S) bounded molecular volume and molecular mass (M). Calculation of log 
P is carried out using atomic parameters derived by Viswanadhan and coworkers [54].  
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Log P is one criterion used in medicinal chemistry to assess the drug likeness of a given 
molecule, and used to calculate lipophilic efficiency, a function of potency and log P that 
evaluate the quality of research compounds. For a given compound lipophilic efficiency is 
defined as the pIC50 (or pEC50) of interest minus the log P of the compound. 
Computation of molar refractivity was made via the same method as log P. Ghose and 
Crippen presented atomic contributions to the refractivity [55]. Solvent-accessible surface 
bounded molecular volume and van der Waals-surface-bounded molecular volume 
calculations are based on a grid method derived by Bodor et al.,[56] using the atomic radii of 
Gavezotti [57].  Polarizability was estimated from an additivity scheme given by Miller with a 
3% in precision for the calculation [58], where different increments are associated with 
different atom types. 
Hydration energy is a key factor determining the stability of different molecular 
conformations in water solutions[59]. The calculation is based on exposed surface area as 
computed by the approximate method (above), weighted by atom type. 
 
3.2 . Structural Comparison of the 14-membered Macrolide Derivatives 
Based on our conclusions on the effect of substitution on the 14-membered 
Macrolides molecules. We chose a series of 14-membered Macrolide derivatives in Table 
4.6, Table 4.7 and Table 4. .8 ; some of them have a biological activity (anti-tuberculosis). 
Initially, we performed a structural comparison of this series. We used molecular mechanics, 
with MM+ force-field to calculate the stable conformations of this series. In a window of 40 
kcal/mol, only one favored conformations is found, for each structure. These molecules have 
a structural differences in specific sites : C2, C3, C6, C9, C11, C2' and C4" as shown in the 
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Table 4.6  14-membered Macrolide derivatives (Structure A). 
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Table 4.7 14-membered Macrolide derivatives (Structure B). 
     













































































B7 RU62041 [32] 8.19 H =O H Me  
B8 RU62543 [32] 8.71 H =O H Me  
B9 RU60849 [32] 8.84 H =O H Me 
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3.3 Structure Property/Activity Relationships 
Lipophilicity is a property that has a major effect on solubility, absorption, distribution, 
metabolism, and excretion properties as well as pharmacological activity. Lipophilicity has 
been studied and applied as an important drug property for decades. It can be quickly 
measured or calculated. 
Lipophilicity has been correlated to many other properties, such as bio availability, 
storage in tissues, permeability, volume of distribution, toxicity, plasma protein binding and 
enzyme receptor binding [60-61]. 
Polarizability values are generally proportional to the values of surfaces and of 
volumes, the order of polarizability is approximately the same one for volume and surface. 
This also is explained by the relation between polarizability and volume, for the relativity non 
polar molecules. They are directly linked, for the centers of gravity of negative and positive 
charges in the absence of external fields to coincide, and the dipole moment of the molecule 
is zero. The polarizability of a molecule depends only on its volume, which means that the 
thermal agitation of non polar molecules does not have any influence on the appearance of 
dipole moments in these molecules. 
On the other hand, for the polar molecules, the polarizability of the molecule does not 
depend solely on volume but also depends on other factors such as the temperature because 
of the presence of the permanent dipole [62]. 
We found for these macrolides that their surfaces vary from 875 to 1226 Å2. These 
macrolides have a considerable variation of distribution volume, in particular compound A11, 
A13 and compound A12 which have respective volumes: 2739.69, 2647.39 and 2643.51 Å3 
(Table 4.9).  
The most important hydration energy  in the absolute value, is that of the compound 
B27 (-18.89 kcal/mol) and the weakest is that of compound B7 (-1.01 kcal/mol) (Table 4.9). 
Indeed, in the biological environments the polar molecules are surrounded by water 
molecules. They are established hydrogen bonds between a water molecule and these 
molecules. The donor sites of the proton interact with the oxygen atom of water and the 
acceptor sites of the proton interact with the hydrogen atom.  
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The first corresponds to the complex with the strongest hydrogen bond. These 
hydrated molecules are dehydrated at least partially before and at the time of their 
interaction. These interactions of weak energy, which we observe in particular between 
messengers and receivers, are generally reversible [63]. 
All (log P) of studied molecules have optimal values. For good oral bio availability, the log P 
must be greater than zero and less than 3 (0 < log P < 3). For log P too high, the drug has low 
solubility and a log P too low; the drug has difficulty penetrating the lipid membranes [60]. 
All the studied compounds Log P have a positive value higher than 3 except two 
compounds: A4 and B2 with Log P values: 3 and 2.44 (Table 4.9), respectively. These two 
Compounds present the low coefficient of division. Order, these molecules possess a good 
solubility. When the coefficient of division is rather low, it has as a consequence a better 
gastric tolerance. Compound A1, B8 and A11 which have, respectively, higher values 7.89, 
7.75 and 7.10 (Table 4.9); these molecules are the most absorbent products and have 
important the capacities to be dependent on plasmatic proteins. 
They are established hydrogen bonds between a water molecule and these molecules. 
The donor sites of the proton interact with the oxygen atom of water and the acceptor sites 
of the proton interact with the hydrogen atom. The first corresponds to the complex with the 
strongest hydrogen bond. These hydrated molecules are dehydrated at least partially before 
and at the time of their interaction. These interactions of weak energy, which we observe in 
particular between messengers and receivers, are generally reversible [63].  
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Figure 4.6. Donor and acceptor sites of compound C4 
 
 
Coumpound A3 has five proton donor sites HBD (5 OH) and 16 proton acceptor sites 
HBA. On the contrary, B3 has only one donor sites HBD and it has 12 proton acceptor sites 
HBA. This property supports the first compound, not only by fixing the receiver, but also 
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A1 2270.24 1106.61 826.17 7.89 -2.78 89.68 215.53 27.58 
A2 2343.45 1190.89 878.16 6.46 -7.41 96.21 252.38 9.12 
A3 2143.96 1014.46 869.10 4.62 -10.91 90.33 228.94 28.15 
A4 1827.35 875.28 747.96 3 -11.03 76.71 190.78 40.99 
A5 1988.81 957.34 790.00 3.13 -6.05 80.47 199.94 35.6 
A6 2236.38 1058.71 873.18 6.03 -6.03 92.10 229.36 9.03 
A7 2304.10 1079.35 915.21 6.16 -4.29 95.86 238.51 13.6 
A8 2313.69 1061.24 929.24 6.43 -5.16 97.69 243.26 45 
A9 2413.50 1122.91 971.28 6.56 -2.99 101.45 252.41 39 
A10 2201.17 1029.99 873.18 5.91 -6.31 92.10 229.51 16.3 
A11 2739.69 1281.60 1111.42 7.10 -8.85 117.97 304.13 115 
A12 2643.51 1200.37 1105.38 6.14 -11.15 117.39 307.22 48.0 
A13 2647.39 1153.65 1119.40 6.54 -11.09 119.23 311.82 107 
A14 2359.49 1059.25 986.21 4.19 -10.96 102.58 265.41 6.8 
A15 2190.01 1049.17 881.11 4.11 -9.28 91.48 232.26 39 
A16 1797.83 869.88 714.94 4.15 -5.55 74.40 185.78 73 
A17 1834.32 897.61 700.95 5.05 -5.69 74.45 186.09 45 
B1 2271.71 1039.66 956.23 4.36 -4.75 101.05 258.75 8.1 
B2 2309.10 1061.75 972.23 2.44 -7.64 101.69 258.81 26.96 
B3 1865.23 897.83 742.95 5.66 -2.21 79.01 204.45 104.8 
B4 2036.77 951.69 821.06 6.53 -3.56 88.87 231.85 24.25 
B5 2013.71 948.81 822.05 5.05 -4.93 88.16 228.28 7.37 
B6 2060.82 1019.90 845.47 3.94 -4.50 87.96 227.58 6.93 
B7 1971.64 981.00 756.98 5.96 -1.01 80.85 208.58 8.19 
B8 2107.06 1076.61 777.05 7.75 2.08 83.12 210.67 8.71 
B9 1935.85 932.56 758.99 6.31 -3.51 81.04 207.93 8.84 
B10 1920.42 937.56 759.98 4.20 -8.01 80.56 206.88 26.04 
B11 2142.51 1090.01 853.00 3.37 -10.89 86.53 225.38 24.29 
B12 1883.92 892.31 765.94 3.98 -5.85 80.82 210.77 102.4 
B13 2281.52 1051.19 957.21 2.94 -6.77 100.56 257.52 38.8 
B14 2342.81 1057.68 999.25 3.07 -3.82 104.32 266.67 13.5 
B15 1950.10 903.19 830.98 4.21 -6.54 86.01 226.54 35.0 
B16 2354.64 1113.10 991.19 3.97 -11.59 102.38 266.06 12 
B17 2604.01 1226.50 1095.3 5.25 -10.76 113.96 299.53 37.0 
B18 2257.98 1055.55 956.20 4.02 -8.39 99.27 256.35 27.7 
B19 1895.45 908.85 795.99 4.27 -5.79 82.90 216.83 11.9 
B20 1922.60 930.89 813.98 4.08 -5.27 82.81 216.61 44 
B21 1875.81 896.79 795.99 2.77 -5.16 82.90 216.56 15.0 
B22 1913.98 933.85 798.91 3.74 -9.50 79.74 206.78 35.4 
B23 2027.11 986.08 848.97 3.90 -9.50 85.92 226.25 51.3 
B24 2238.18 1080.74 953.07 5.18 -10.68 97.50 259.71 42.4 
B25 1999.39 951.82 846.05 4.34 -4.79 89.09 235.03 14.07 
B26 1888.72 904.79 800.97 4.37 -16.66 81.19 214.21 51.1 
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B27 2311.64 1116.73 961.18 4.12 -18.89 97.56 253.74 18.9 
B28 2321.25 1123.44 961.18 4.12 -14.99 97.56 253.74 48.2 
C1 2277.58 1035.21 957.21 3.92 -5.66 100.56 257.45 24.93 
C2 1950.02 915.10 797.00 4.17 -3.24 84.19 217.93 26.34 
C3 2085.33 973.70 839.08 5.36 -4.10 89.70 231.73 7.32 
C4 1868.78 933.64 731.93 5.08 -3.23 76.89 197.43 46.7 
C5 2474.24 1122.57 1061.32 5.20 -4.65 112.14 290.92 5.5 
 
3.4 Drug likeness screening of 14-membered macrolide derivatives 
Drug-likeness appears as a promising paradigm to encode the balance among the 
molecular properties of a compound that influences its pharmacodynamics and 
pharmacokinetics and ultimately optimizes their absorption, distribution, metabolism and 
excretion (ADME) in human body like a drug [64-65]. The empirical conditions to satisfy 
Lipinski’s rule and manifest a good oral bio availability involve a balance between the 
aqueous solubility of a compound and its ability to diffuse passively through the different 
biological barriers. 
Drug-likeness is a qualitative property of chemicals. This concept is useful in guiding early-
stage drug discovery. It is based on observations of correspondences between 
pharmacological activity of molecular agents and their physicochemical properties. It allows 
connecting the impact of physicochemical properties on molecular behaviors in vivo, with a 
special focus on solubility, permeability, metabolic stability and transporter effects. The best 
compromise results from a subtle balance between physiochemical and pharmacokinetic 
properties. This is critical for designing new drugs [66]. 
These parameters allow to ascertaining oral absorption or membrane permeability that 
occurs when the evaluated molecule follows Lipinski’s rule of five, evaluated molecule follows 
Lipinski’s rule of five, molecular weight (MW) ≤ 500 Da, an octanol-water partition coefficient 
log P ≤ 5, H-bond donors, nitrogen or oxygen atoms with one or more hydrogen atoms (HBD) 
≤ 5 and H-bond acceptors, nitrogen or oxygen atoms (HBA) ≤ 10. 
Table 10 lists the pharmacological activities and properties we deduced for 14-membered 
macrolides derivatives under study. They correspond to partition coefficient octanol/water 
(LogP), molecular weight (MW), hydrogen bond donors (HBD), hydrogen bond acceptors 
(HBA), ligand efficiency (LE) and lipophilic ligand efficiency (LLE). These results were 
calculated using HyperChem 8.0.8. 
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Also, we have studied Lipinski rule to identify “drug-like” compounds. Table 4.10 shows 
that all compounds have a LogP comprised between 2 and 8. LogP values in the range of 1 to 
3 are connected with a good oral bioavailability.  
The drug has hence sufficient aqueous solubility to dissolve in the gastrointestinal contents 
and also adequate lipid solubility to facilitate its partitioning into the lipoid membrane. For 
LogP > 3, the drug has low solubility and for LogP < 1 the drug has difficulty penetrating the 
lipid membranes. 
Ligand efficiency (LE) and lipophilic ligand efficiency (LLE) are defined as  
LE=1.4 * pIC50/NH ,  and LLE = pIC50−LogP where NH is the number of heavy atoms and  
pIC50 = − log (IC50) [67].  
LELP = log P/LE. The optimal LELP scores are -10 < LELP<10 [68]. 
LE is introduced as an important metric in drug discovery, and as a tool of assessing a 
compound’s potency relative to its size. It is dependent on ligand size (with smaller ligands 
having greater efficiencies, on average, than larger ligands) [69-70]. Also, we took advantage 
of LLE to gain a deeper understanding of the effect of structural changes in the series. As a 
rough guide, medicinal compounds in drug-like space have LLE values in the range 5–7 [71]. 
Note that compounds with high LE and LLE interact efficiently with biological targets [72].  
In the studied series, LLE is changing during optimization (Table 4.10). All compounds 
have negative LLE values which are clearly unfavorable. 
above mentioned parameters were calculated for A1- C5 and the results were 
presented in Table 4.10. From the data obtained, it was observed that all derivatives were 
found doesn't obey the Lipinski rule, suggesting that these compounds theoretically would 
have problems with oral bioavailability.  
There is much evidence that despite having molecular mass that are above ‘rule of 5’-
compliant small molecules [73], macrocycles can demonstrate drug like physicochemical and 
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log P HBD HBA No. of 
violations 
pIC50 LLE NH LE LELP 
A1 826.17 7.89 03 13 03 4.56 -3.33 58 0.110 71.73 
A2 878.16 6.46 03 13 03 5.04 -1.42 64 0.110 58.72 
A3 869.10 4.62 05 16 02 4.55 -0.07 61 0.104 44.42 
A4 747.96 3 04 14 02 4.39 1.39 52 0.118 25.42 
A5 790.00 3.13 03 15 02 4.45 1.32 56 0.111 28.19 
A6 873.18 6.03 04 15 03 5.04 -0.99 61 0.116 51.98 
A7 915.21 6.16 04 16 03 4.87 -1.29 64 0.106 58.11 
A8 929.24 6.43 03 16 03 4.35 -2.08 65 0.093 69.13 
A9 971.28 6.56 02 17 03 4.41 -2.15 68 0.090 72.88 
A10 873.18 5.91 04 15 03 4.79 -1.12 61 0.109 54.22 
A11 1111.42 7.10 04 20 03 3.94 -3.16 79 0.069 102.89 
A12 1105.38 6.14 04 20 03 4.32 -1.82 79 0.076 80.78 
A13 1119.40 6.54 04 20 03 3.97 -2.57 80 0.069 94.78 
A14 986.21 4.19 04 19 02 5.17 0.98 70 0.103 40.68 
A15 881.11 4.11 04 16 02 4.41 0.3 68 0.090 45.66 
A16 714.94 4.15 04 14 02 4.14 -0.01 50 0.116 35.77 
A17 700.95 5.05 04 12 03 4.35 -0.7 49 0.124 40.72 
B1 956.23 4.36 02 16 02 5.09 0.73 68 0.105 41.52 
B2 972.23 2.44 02 18 02 4.57 2.13 69 0.093 26.23 
B3 742.95 5.66 01 12 03 3.98 -1.68 53 0.105 53.90 
B4 821.06 6.53 01 12 03 4.61 -1.92 59 0.109 59.91 
B5 822.05 5.05 01 13 03 5.13 0.08 59 0.122 41.39 
B6 845.47 3.94 01 14 02 5.16 1.22 59 0.122 32.29 
B7 756.98 5.96 01 12 03 5.09 -0.87 54 0.131 45.49 
B8 777.05 7.75 01 12 03 5.06 -2.69 55 0.129 60.07 
B9 758.99 6.31 01 12 03 5.05 -1.26 54 0.131 48.17 
B10 759.98 4.20 03 13 02 4.58 0.38 54 0.119 35.29 
B11 853.00 3.37 02 15 02 4.61 1.24 61 0.106 31.79 
B12 765.94 3.98 02 13 02 3.99 0.01 55 0.101 39.40 
B13 957.21 2.94 03 17 02 4.41 1.47 68 0.091 32.30 
B14 999.25 3.07 03 18 02 4.87 1.8 71 0.096 31.98 
B15 830.98 4.21 02 15 02 4.45 0.24 60 0.104 40.48 
B16 991.19 3.97 04 18 02 4.92 0.95 71 0.097 40.92 
B17 1095.30 5.25 03 19 03 4.43 -0.82 79 0.078 67.30 
B18 956.20 4.02 04 17 02 4.56 0.54 67 0.095 42.31 
B19 795.99 4.27 03 13 02 4.92 0.65 56 0.123 34.71 
B20 813.98 4.08 03 13 02 4.36 0.28 57 0.107 38.13 
B21 795.99 2.77 03 13 02 4.82 2.05 56 0.120 23.08 
B22 798.91 3.74 03 15 02 4.45 0.71 57 0.109 34.31 
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B23 848.97 3.90 03 15 02 4.29 0.39 61 0.098 39.79 
B24 953.07 5.18 02 16 03 4.37 -0.81 69 0.088 58.86 
B25 846.05 4.34 03 13 02 4.85 0.51 60 0.113 38.40 
B26 800.97 4.37 03 16 02 4.29 -0.08 56 0.107 40.84 
B27 961.18 4.12 04 19 02 4.72 0.6 67 0.098 42.04 
B28 961.18 4.12 04 19 02 4.32 0.2 67 0.090 45.77 
C1 957.21 3.92 03 17 02 4.60 0.68 68 0.095 41.26 
C2 797.00 4.17 02 14 02 4.58 0.41 57 0.112 37.23 
C3 839.08 5.36 02 14 03 5.13 -0.23 60 0.119 46.20 
C4 731.93 5.08 02 13 03 4.33 -0.75 52 0.116 43.79 
C5 1061.32 5.20 02 18 03 5.26 0.06 76 0.097 53.61 
 
4. Quantitative structure-activity relationships studies  
The field of quantitative structure–activity relationships (QSARs) deals with 
development of predictive models correlating biological activity of a compound with its 
physicochemical properties [74]. The quantitative approach depends upon expression of a 
structure by numerical values and then relating these values to the corresponding changes in 
the biological activity by using statistical methods [75]. The series of fifty macrolides 
derivatives was used for multi linear regression model generation using the SPSS software 
package. Different physicochemical descriptors were used as independent variables and were 
correlated with anti-TB activity (pIC50) Pearson’s correlation matrix has been performed on all 
descriptors. The analysis of the matrix revealed five descriptors for the development of MLR 
models. The values of the descriptors used in MLR analysis are presented in Tables 4.9 and 
4.10. 
The correlation between the biological activity (IC50) and the descriptors can be expressed by 
the following relation : 
 
𝑝𝐼𝐶50 = −3.785 − 0.036 × Logp + 0.006 × Mass + 41.429 ×  LE − 0.041 ×  HBD    
 
To derive this equation, 50 Compounds were considered. In this equation, the 
negative coefficients of logp and HBD explain that any increase in hydrogen bond donors or 
logp of the compounds causes a decrease in the biological activity. 
The values of fraction variance, r, may vary between 0 and 1.  
 
 
CHAPITER 4: Drug-likeness properties and Structure activity Relationships of 




QSAR models having r 0.6 >2will only be considered for validation. Here, r is equal to 
0.952 and r2  =0.907  , which allows us to indicate firmly the correlation between the 
independent variables with respect anti-TB activity. The F-value has found to be statistically 
significant at 95  % level, since the obtained F value (of 109.268) is relatively high . 
The positive value of quality factor (Q = 8.424) for this QSAR model suggests its high 
predictive power and lack of over fitting . 
In order to confirm the validity of the predictive power of selected MLR models, the leave-
one-out technique (LOO technique) was used. The developed model was validated by 
calculation of the following statistical parameters: predicted residual sum of squares )PRESS), 
total sum of squares deviation (SSY), SPRESS(predicted squares error) the predictive error of the 
coefficient of correlation ) PE) and cross-validated correlation coefficients (R2adj and R2cv). We 
computed the following cross-validation parameters:  
PRESS = 0.573 , SSY = 6.137, PRESS/SSY = 0.093,  S PRESS =0.107  , R2 cv =  0.907 , R2 adj 
0.898 =  and  6 × PE = 0.017. 
PRESS is a good estimate of the real predictive error of the model . If PRESS is smaller 
than the sum of the squares of the response values (SSY), then the model can be considered 
statistically significant  [  ,76  ] which is the case presently. The ratio PRESS/SSY can be used to 
calculate approximate confidence intervals of prediction of a new compound. This ratio is 
equal to 0.093, which is smaller than 0.4, indicating that we have a reasonably good model as 
established in Ref ]77 [ . Also, the high values of r2cv and r2adj are essential criteria for the best 
qualification of the QSAR model.  
Our results for these two values are 0.907 and 0.898, respectively. Finally, we show 
that the condition r > 6 × PE is satisfied. Again, this confirms the good predictive power of the 
model. Figure 3.6 shows the plots of linear regression of predicted versus experimental values 
of the biological activity outlined above. The plots for our model show a good 
correspondence with experimentally reported data (r2 = 0.907)  .The plot of residuals of 
predicted values of the biological activity pMIC against the experimental values does not 
show any systematic error (Figure 4.7) positive and negative residuals are randomly 
distributed. Thus, this confirms further that our QSAR model can be successfully applied to 
predict anti-TB activity . 
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 The present study, offers the ability to guide design and selection to quickly identify 
compounds from the 14-membered macrolide derivatives. Series that are likely to achieve 
outcome in the clinic and occupy a strong market position. Also, it provides a discussion of 
several qualitative approximations of the structure activity/property relationship.  
The compounds A1-C5 doesn't obey the Lipinski rule, suggesting that these compounds 
theoretically would have problems with oral bioavailability.  
The QSAR model is used to predict inhibitory activity of the macrolide derivatives 
investigated and close agreement between experimental and predicted values was obtained. 
𝑝𝐼𝐶50 = −3.785 − 0.036 × Logp + 0.006 × Mass + 41.429 ×  LE − 0.041 ×  HBD 
 The validity of the model has been established by the determination of suitable 
statistical parameters. A low residual activity and a high cross-validated values are obtained. 
These suggest a good predictive ability of the developed QSAR model.  
  
  
Figure 4.7 Left: Plots of predicted (y-axis) versus experimentally (x-axis) observed pIC50. Right: Plots of 
residual against experimental values pIC50 
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 Also, they indicate that the activity of the studied macrolide derivatives can be 
successfully modeled using various molecular descriptors. 
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In this work, we applied the methods of computational chemistry on 14-
membered macrolide molecules, this study include:  
• Geometric, electronic structure and substituent effects. 
• Computational study of structure -property relationships (SPR) for 14-
membered macrolide derivatives. 
•  QSAR modeling of some 14-membered macrolide derivatives  
Firstly, the results demonstrate that the structural and electronic comparison of 
nucleus of 14-membered macrolides present similar results using different calculation 
methods: semi-empirical method (PM3) and Ab initio quantum methods. 
  The 4, 10-di-methyl macrolide is predicted to be the most reactive with least 
HOMO-LUMO energy gap (4.4141) of all macrolide systems substituted by di-methyl, 
and in the substituted di-fluorine group category, the 4,10-fluorinemacrolide has 
smaller HOMO-LUMO energy gap (4.2463). depicts high chemical reactivity of the 
compounds 
Then, the results of research on the structure-property relationship (SPR) of the 
14-membered macrolides derivatives series have shown that structural units involved 
in the biological activity.  
The compounds A1, A11 and B8 which have higher values of partition 
coefficient. These lipophilic compounds penetrate in various membranes, including 
cellular membranes as well as tissues with high lipoid content, to arrive at the 
receptor site. Compound B27 has important hydration energy leading to a better 








Molecular properties such as membrane permeability and oral bioavailability 
are usually associated with some basic molecular descriptors, such as log P (partition 
coefficient), molecular weight (MW), and the acceptors and donor for hydrogen 
bonding in a molecule. Using these molecular properties, Lipinski established a 
controversial rule for drug design. 
 The compounds A1-C5 doesn't obey the Lipinski rule, suggesting that these 
compounds theoretically would have problems with oral bioavailability.  
  Finally, Quantitative structure activity relationship (QSAR) studies were 
performed on a series of 14-membered macrolides as antibiotiques, multiple linear 
regression analysis was performed to derive quantitative structure activity relationship 
models which were further evaluated internally for the prediction of activity. The 
developed models were cross-validated by the ‘leave one out’ technique as well as by 
the calculation of statistical parameters.  
The QSAR model is used to predict inhibitory activity of the macrolide 
derivatives investigated and close agreement between experimental and predicted 
values was obtained.  
 The validity of the model has been established by the determination of suitable 
statistical parameters. A low residual activity and a high cross-validated values are 
obtained. These suggest a good predictive ability of the developed QSAR model.  
 Also, they indicate that the activity of the studied macrolide derivatives can be 




























The frontier molecular orbitals







The frontier molecular orbitals HOMO and LUMO of 
14-membered Macrolide derivatives (series 1) 
 
 
Comp.1   R1=R2=R3=R4=R5=R6=R7=R8=R9=R10=R11=R12=H 
Comp.2   R1=R7=CH3, R2=R3=R4=R5=R6=R8=R9=R10=R11=R12=H 
Comp.3   R2=R8=CH3, R1=R3=R4=R5=R6=R7=R9=R10=R11=R12=H 
Comp.4   R3=R9=CH3, R1=R2=R4=R5=R6=R7=R8=R10=R11=R12=H 
Comp.5   R4=R10=CH3, R1=R2=R3=R5=R6=R7=R8=R9=R11=R12=H 
Comp.6   R5=R11=CH3, R1=R2=R3=R4=R6=R7=R8=R9=R10=R12=H 
Comp.7   R6=R12=CH3, R1=R2=R3=R4=R5=R7=R8=R9=R10=R11=H 
 























































The frontier molecular orbitals HOMO and LUMO of 
14-membered Macrolide derivatives (series 2) 
 
 
Comp.1   R1=R2=R3=R4=R5=R6=R7=R8=R9=R10=R11=R12=H 
Comp.2   R1=R7=F, R2=R3=R4=R5=R6=R8=R9=R10=R11=R12=H 
Comp.3   R2=R8= F, R1=R3=R4=R5=R6=R7=R9=R10=R11=R12=H 
Comp.4   R3=R9= F, R1=R2=R4=R5=R6=R7=R8=R10=R11=R12=H 
Comp.5   R4=R10= F, R1=R2=R3=R5=R6=R7=R8=R9=R11=R12=H 
Comp.6   R5=R11= F, R1=R2=R3=R4=R6=R7=R8=R9=R10=R12=H 
Comp.7   R6=R12= F, R1=R2=R3=R4=R5=R7=R8=R9=R10=R11=H 
 






































































3D Structure of 14- Membered 














































































































































































































































































































































































































































































































































































































ي  14المكروليد ذات     العمل بحث أساسي و أصلي حول حلقة  ف ذرة و الھدف من ذلك ھو توقع الفعالیة والنشاط البیولوج 
ونیة لال .للمركب المدروس و مشتقاته ي حالة وجود المستبدل تم  ذرة 14نواة المكروليد ذات  معاییر الھیكلیة و االلكیر
 
ي حالتھا األساسیة و ف
 
ف
ا  التالیة : حسابھا باستخدام  البنيوية   ,PM3.و     +ab initio/HF( STO- 3G), MMلطرق  العوامل  الطرق استعملت من اجل تحديد  هذه 
كة للجزيئات المدروسة. طبيعة نمط المستبدل )مانح ،, ونية و الطاقوية المشیر ونية و الطاقوية للنواة  االلكیر مستقبل( تؤثر عل العوامل االلكیر
ذات    للمكروليدات  لمشتقات  الكیمیائیة  الفعالیة  بتوقع  لنا  تسمح  ة  األخیر الدراسة  ھذه   
َ
فان الواقع  ي 
 
ف للمكروليد.  و كذا   14األساسية  ذرة 
 .ذرة النشطة بیولوجیا  14المكروليدات ذات   ن مشتقاتلسلسلة م(SPR) خصائص –وقد تم أیضا القیام بدراسة نوعیة بنیة  . الكيتوليدات
بنیة   الكمیة  العالقة  بدراسة  قمنا  ا  البیولوجیة    –وأخیر المكروليد ذات        (QSAR)فعالیة  لھم فعالیة  ذرة    14لخمسير  مركب من مشتقات 
( حيويةبیولوجیة  اإلحصائیة مضادات  الطریقة  استخدمنا  وقد   ) MLR  ي
ریاض  نموذج  لتصمیم  النظریة    QSAR وذلك  بالقیم  التنبؤ  لغرض 
وكذلك بعض المعاییر االحصائیة.  LOO ولتأكد من صحة و فعالیة ھذا النموذج استخدمنا طریقة  .للفعالیة البیولوجیة عن طریق ھذا النموذج
 .المتحصل علیھا   QSAR النموذج ولقد الحظنا شدة التقارب بير  القیم النظریة و التجریبیة للفعالیة البیولوجیة مما یؤكد فعالیة و جودة
 
Résumé : 
Dans ce travail, une recherche fondamentale et originale sur les macrolides à 14 chaînons a est réalisée 
dans le but est de prédire de la réactivité et de l'activité biologique du composé étudié et ses dérivés. Les 
méthodes de modélisation moléculaire utilisées dans notre travail sont :MM+, PM3 et ab initio/HF(STO- 3G). 
Ces méthodes ont été utilisées pour déterminer les paramètres structuraux, électroniques et énergétiques 
associés aux molécules étudiées. La nature de type de substituant ( donneur, accepteur) influe sur les 
paramètres électroniques et énergétiques de noyau de base de macrolide. En effet, cette étude nous a permet de 
prédire la réactivité chimique des dérivés des macrolides à 14 chaînons. Une étude qualitative de la relation 
structure-propriétés (SPR) a été effectuée également pour une série bioactive de dérivés des macrolides à 14 
chaînons et aussi des kétolides. Une étude QSAR a été effectuée sur  une cinquantaine de molécules analogues 
de les macrolides à 14 chaînons. Les composés utilisés sont caractérisés par son effet des antibiotiques. La 
régression linéaire multiple (MLR) a été utilisée pour quantifier les relations entre les descripteurs 
moléculaires et la propriété de l’activité antibiotique des dérivés des macrolides à 14 chaînons. La prédiction 
des modèles obtenus a été confirmé par la méthode de validation croisée LOO. Une forte corrélation a été 
observée entre les valeurs expérimentales et les valeurs prédites de l’activité antiproliférative, ce qui indique la 
validité et la qualité des modèles QSAR obtenus. 
 
Abstract: 
 In this work a fundamental and original research on the 14- membered macrolide, the aim is to 
predict the reactivity and biological activity of the compound studied and its derivatives. The molecular 
modeling methods used in our work are: MM+, PM3 and ab initio/HF(STO- 3G). These methods were used to 
determine the structural parameters, electronics and energy associated with molecules studied. The nature of 
such substituent (donor, acceptor) affects the electronic and energy parameters of basic core of the 14- 
membered macrolide. Indeed, this qualitative study allows us to predict the chemical reactivity of derivatives 
of the 14- membered macrolide and also the ketolides. A study of structure - property relationships (SPR) for 
the 14- membered macrolide derivatives has been carried out for a series of bioactive derivatives of the 14- 
membered macrolide. QSAR studies have been performed on fifty molecules of the 14- membered macrolide 
as the antibiotics, multiple linear regression analysis was performed to derive QSAR models which were 
further evaluated internally for the prediction of activity. The developed models were cross-validated by the 
‘leave one out’ technique as well as by the calculation of statistical parameters LOO. High correlation between 
experimental and predicted activity values was observed, indicating the validation and the good quality of the 
derived QSAR models. 
 
